<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="systematic-review" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Aging Neurosci.</journal-id>
<journal-title>Frontiers in Aging Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Aging Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1663-4365</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnagi.2025.1598608</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Aging Neuroscience</subject>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Unveiling the glymphatic system&#x2019;s impact on neurodegenerative diseases: a comprehensive bibliometric analysis (2012&#x2013;2024)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wang</surname> <given-names>Younian</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2971055/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname> <given-names>Qiangsheng</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Wu</surname> <given-names>Junyi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2752623/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Meng</surname> <given-names>Kun</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Zhou</surname> <given-names>Lanting</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Ye</surname> <given-names>Fan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Hubei University of Arts and Science</institution>, <addr-line>Xiangyang</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Anesthesiology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science</institution>, <addr-line>Xiangyang</addr-line>, <country>China</country></aff>
<aff id="aff3"><sup>3</sup><institution>Institute of Neuroscience and Brain Science, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science</institution>, <addr-line>Xiangyang</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0001">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/111489/overview">Geert Bultynck</ext-link>, KU Leuven, Belgium</p>
</fn>
<fn fn-type="edited-by" id="fn0002">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/175990/overview">Adriana Ximenes-da-Silva</ext-link>, Federal University of Alagoas, Brazil</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1789177/overview">Yuan Xu</ext-link>, Changzhou First People&#x2019;s Hospital, China</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Fan Ye, <email>fanye@hbuas.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>09</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>17</volume>
<elocation-id>1598608</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>03</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>09</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Wang, Liu, Wu, Meng, Zhou and Ye.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Wang, Liu, Wu, Meng, Zhou and Ye</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>The glymphatic system is a crucial factor in the development of neurodegenerative diseases (NDs) and holds substantial promise for therapeutic strategies. However, despite its growing significance, detailed bibliometric investigations specifically targeting the interplay between the glymphatic system and NDs are still sparse. This study pioneers a comprehensive bibliometric analysis to delineate the intellectual framework and emerging trajectories in glymphatic system research associated with NDs.</p>
</sec>
<sec id="sec2">
<title>Materials and methods</title>
<p>We conducted an exhaustive search of the literature on the glymphatic system and NDs using the Web of Science Core Collection (WoSCC), Scopus, and Pubmed Central (PMC) databases. VOSviewer was applied for bibliometric analysis and visualization to scrutinize geographical distribution, institutional distribution, inter-journal connections, and keyword prevalence. Additionally, CiteSpace was utilized to intuitively explore and analyze journal interactions and citation dynamics. The bibliometrix R package was employed to construct visualized networks of international collaborations, as well as the relationships among authors, keywords, and journals. Data visualization was further enhanced with the aid of the WPS Office.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>A total of 865 relevant publications were retrieved, covering 92 countries, 1,471 research institutions, and 367 academic journals. Over the past thirteen years, both the number of publications and citations related to the glymphatic system in NDs have shown a significant upward trend, with neuroscience being the primary research field. Chinese authors over the world published the largest number of articles, while China and United States rank the highest in terms of publication and citation counts, also both demonstrate extensive international collaboration. And the <italic>Frontiers series journal</italic> publishes the most papers in this field, while <italic>Brain</italic> is the most frequently cited journal. The University of Rochester is the top-producing institution with an internally well-known Chinese research group. Keyword analysis highlights the glymphatic system, Alzheimer&#x2019;s disease (AD), cerebrospinal fluid, and aquaporin 4 (AQP4) as core topics, with AQP4 polarization identified as a key regulatory factor for metabolic waste clearance. The main NDs under investigation are AD and Parkinson&#x2019;s disease (PD).</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>This study offers a comprehensive preliminary dissection of the research landscape, identifying current focal points and potential future directions in glymphatic system research related to NDs. By leveraging multiple bibliometric approaches, this study provides valuable insights into this burgeoning field.</p>
</sec>
</abstract>
<kwd-group>
<kwd>glymphatic system</kwd>
<kwd>neurodegenerative diseases</kwd>
<kwd>Aquaporin-4</kwd>
<kwd>Alzheimer&#x2019;s disease</kwd>
<kwd>bibliometrics</kwd>
</kwd-group>
<counts>
<fig-count count="10"/>
<table-count count="8"/>
<equation-count count="0"/>
<ref-count count="67"/>
<page-count count="26"/>
<word-count count="14660"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Alzheimer's Disease and Related Dementias</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5">
<label>1</label>
<title>Introduction</title>
<p>Neurodegenerative diseases (NDs) manifest through progressive neuronal degeneration in specific CNS regions, encompassing Alzheimer&#x2019;s disease (AD), Parkinson&#x2019;s disease (PD), multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), and Huntington&#x2019;s disease (HD) (<xref ref-type="bibr" rid="ref20">Guo et al., 2022</xref>). These conditions share core neuropathological signatures including chronic neuroinflammation and pathological protein conglomerates. AD is pathologically defined by two hallmark features: extracellular deposition of <italic>&#x03B2;</italic>-amyloid (A&#x03B2;) plaques and intraneuronal accumulation of hyperphosphorylated Tau protein-laden neurofibrillary tangles, a dual pathogenic mechanism extensively corroborated in modern neuropathological paradigms (<xref ref-type="bibr" rid="ref2">Andrade-Guerrero et al., 2023</xref>). PD presents selective dopaminergic neuron loss within the substantia nigra pars compacta accompanied by <italic>&#x03B1;</italic>-synuclein-enriched Lewy bodies (<xref ref-type="bibr" rid="ref65">Zhou et al., 2024</xref>). HD stems from abnormal Cytosine-Adenine-Guanine (CAG) trinucleotide expansion in the huntingtin (HTT) gene, driving progressive striatal and cortical neuron degeneration (<xref ref-type="bibr" rid="ref13">Chang et al., 2024</xref>; <xref ref-type="bibr" rid="ref51">Thipani Madhu et al., 2024</xref>). These pathogenic aggregates not only disrupt neuronal equilibrium but also amplify neural injury through innate immune activation and oxidative cascades (<xref ref-type="bibr" rid="ref31">Kritsilis et al., 2018</xref>). Of critical concern is the global surge in NDs prevalence due to population aging, which imposes an escalating socioeconomic strain on healthcare infrastructures (<xref ref-type="bibr" rid="ref9">Bhattacharya et al., 2022</xref>). NDs trigger irreversible neurological impairments including cognitive deterioration, motor deficits, and emotional dysregulation, which collectively degrade patients&#x2019; functional independence. This clinical reality underscores the imperative to decode disease mechanisms and formulate precision interventions. The brain&#x2019;s glymphatic network first mapped in 2012 through pioneering rodent studies serves as a macroscopic clearance pathway mediating cerebrospinal-interstitial fluid exchange (<xref ref-type="bibr" rid="ref27">Iliff et al., 2012</xref>). This pathway facilitates efficient clearance of neurotoxic metabolites like A&#x03B2; and Tau proteins through arteriole pulsation-driven paravascular flux, a process modulated by astrocytic endfoot aquaporin 4 (AQP4) water channel polarization (<xref ref-type="bibr" rid="ref39">Naganawa et al., 2024</xref>). Notably, glymphatic activity exhibits circadian rhythmicity, with enhanced function during non-rapid eye movement sleep, suggesting that sleep disturbances may contribute to NDs progression via impaired metabolic clearance (<xref ref-type="bibr" rid="ref19">Gottesman et al., 2024</xref>). Accumulating evidence indicates that glymphatic dysfunction disrupts the homeostasis of pathogenic proteins (e.g., A&#x03B2;, <italic>&#x03B1;</italic>-synuclein), directly implicating this system in the etiopathogenesis of AD, PD, and other NDs (<xref ref-type="bibr" rid="ref8">Beschorner and Nedergaard, 2024</xref>; <xref ref-type="bibr" rid="ref58">Yamada and Iwatsubo, 2024</xref>). Thus, targeting glymphatic pathways emerges as a promising therapeutic strategy for NDs intervention. With the deepening understanding of the pathophysiological mechanisms of the glymphatic system, researchers are actively developing <italic>in vivo</italic> detection technologies to quantitatively assess its function. In recent years, advanced neuroimaging techniques such as dynamic contrast-enhanced MRI (DCE-MRI), diffusion tensor imaging along the perivascular space (DTI-ALPS), and ultra-high-resolution PET tracers have been employed to quantitatively evaluate human glymphatic transport efficiency in vivo. <xref ref-type="bibr" rid="ref39">Naganawa et al. (2024)</xref> and <xref ref-type="bibr" rid="ref45">Ringstad et al. (2018)</xref> successively used intrathecal gadolinium-enhanced DCE-MRI to map cerebrospinal fluid-interstitial fluid (CSF-ISF) exchange in real time at a whole-brain scale, establishing standardized rate and clearance metrics. <xref ref-type="bibr" rid="ref65">Zhou et al. (2024)</xref> and <xref ref-type="bibr" rid="ref42">Premi et al. (2024)</xref> further applied DTI-ALPS and multimodal MRI to Parkinson&#x2019;s disease and genetic frontotemporal dementia cohorts, respectively, demonstrating that reduced glymphatic transport efficiency significantly correlates with motor milestone risk and disease severity. <xref ref-type="bibr" rid="ref54">Wilson et al. (2020)</xref> and <xref ref-type="bibr" rid="ref5">Bah et al. (2023)</xref> proposed that novel PET tracers combined with computational fluid dynamics models could elucidate fluid dynamic alterations associated with aging and dementia at the molecular level, attributing glymphatic clearance impairment to diminished CSF pulsatility and reduced vascular compliance. These studies not only provide directly measurable glymphatic functional parameters but also establish a dual foundation&#x2014;at both imaging and molecular levels&#x2014;for clarifying the system&#x2019;s mechanistic role in various NDs.</p>
<p>Bibliometrics, an interdisciplinary field employing mathematical and statistical methodologies to analyze academic literature (<xref ref-type="bibr" rid="ref32">Liu et al., 2024b</xref>; <xref ref-type="bibr" rid="ref50">Sun et al., 2023</xref>), provides systematic insights into knowledge structures, collaborative networks, research frontiers, and evolutionary trends within specific domains. Despite significant advancements in glymphatic research related to NDs, a comprehensive bibliometric analysis mapping the intellectual landscape of this field remains absent. This study pioneers the integration of CiteSpace (v6.3. R1), VOSviewer (v1.6.20), and Bibliometrix R package to conduct a multidimensional bibliometric analysis of original research articles on the glymphatic system in NDs published between 2012 and 2024. By constructing scientometric knowledge maps, we aim to delineate core research clusters, interdisciplinary intersections, and paradigm shifts, providing strategic guidance for future mechanistic explorations and translational applications in NDs research.</p>
</sec>
<sec sec-type="materials|methods" id="sec6">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec7">
<label>2.1</label>
<title>Data collection</title>
<p>Selecting multiple academic databases and formulating an effective retrieval strategy are crucial for acquiring high-quality datasets. In this study, the WOSCC (Clarivate 2025-03-01), Scopus (Elsevier 2025-03-01), PMC (NLM 2025-03-01) were selected as the data sources to provide comprehensive support for the literature analysis. WOSCC, which encompasses the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts &#x0026; Humanities Citation Index (A&#x0026;HCI), and Emerging Sources Citation Index (ESCI), offers authoritative publications in the research field of the glymphatic system and neurodegenerative diseases. Scopus, recognized as the largest abstract and citation database covering a broad range of disciplines, provides extensive peer-reviewed literature. PMC, a full-text repository, offers free and open access to a growing archive of biomedical and life sciences journal literature indexed in PubMed. Given their extensive coverage and high-quality content, WOSCC, Scopus, and PMC were chosen as the primary data sources for this research.</p>
<p>To systematically obtain articles in this field, the search strategy employed the following Boolean query: TS&#x202F;= (&#x201C;glymphatic system&#x201D; OR &#x201C;glymphatic pathway&#x201D; OR &#x201C;Glymphatic Pathways&#x201D; OR &#x201C;Pathway, Glymphatic&#x201D; OR &#x201C;Glymphatic Clearance System&#x201D; OR &#x201C;glymphatic&#x201D; OR &#x201C;glial lymphatic&#x201D; OR &#x201C;Brain Perivascular Spaces&#x201D; OR &#x201C;Brain Perivascular Space&#x201D; OR &#x201C;Perivascular Space, Brain&#x201D; OR &#x201C;paravascular pathway&#x201D;) AND TS&#x202F;= (&#x201C;Neurodegenerative Diseases&#x201D; OR &#x201C;Degenerative Diseases, Neurologic&#x201D; OR&#x201C;Neurologic Degenerative Disease&#x201D; OR &#x201C;Degenerative Neurologic Diseases&#x201D; OR &#x201C;Degenerative Neurologic Disease&#x201D; OR &#x201C;Neurologic Disease, Degenerative&#x201D; OR &#x201C;Neurologic Diseases, Degenerative&#x201D; OR &#x201C;Nervous System Degenerative Diseases&#x201D; OR &#x201C;Neurodegenerative Disorders&#x201D; OR &#x201C;Neurodegenerative Disorder&#x201D; OR &#x201C;Neurologic Degenerative Conditions&#x201D; OR &#x201C;Degenerative Condition, Neurologic&#x201D; OR &#x201C;Degenerative Conditions, Neurologic&#x201D; OR &#x201C;Neurologic Degenerative Condition&#x201D; OR &#x201C;Neurologic Degenerative Diseases&#x201D; OR &#x201C;Degenerative Diseases, Nervous System&#x201D; OR &#x201C;Degenerative Neurologic Disorders&#x201D; OR &#x201C;Degenerative Neurologic Disorder&#x201D; OR &#x201C;Neurologic Disorder, Degenerative&#x201D; OR &#x201C;Neurologic Disorders, Degenerative&#x201D; OR &#x201C;Degenerative Diseases, Spinal Cord&#x201D; OR &#x201C;Degenerative Diseases, Central Nervous System&#x201D;OR &#x201C;Alzheimer&#x2019;s Disease&#x201D; OR &#x201C;Parkinson&#x2019;s Disease&#x201D; OR &#x201C;Multiple Sclerosis&#x201D; OR &#x201C;Amyotrophic Lateral Sclerosis&#x201D; OR &#x201C;Huntington&#x2019;s Disease&#x201D;). The document types were specifically designated as &#x201C;article&#x201D; and &#x201C;review article&#x201D; to ensure the high quality of the data sources. Review articles were selected for their capacity to synthesize high-quality research findings, identify research gaps, and propose potential solutions. The publication date was restricted to the period from January 1, 2012, to December 31, 2024, and the language was limited to English. Initially, a total of 1,689 articles were retrieved, with 579 from the WOSCC, 773 from Scopus, and 337 from PMC. After removing duplicates and excluding articles that were unrelated to the theme or lacked essential information such as DOI, volume, start page, keywords, and references, a final dataset of 865 publications was retained for analysis (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Study flow diagram.</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Flowchart depicting a bibliometric analysis process across four stages: Identification, Selection, Analysis, and Discussion. In Identification, databases like Web of Science, Scopus, and PubMed are searched for articles on the glymphatic system and neurodegenerative diseases, resulting in 1,689 hits. Selection steps involve removing duplicates and filtering out unrelated articles, narrowing it to 865 articles. Analysis involves data management with Microsoft Excel and Web of Science, using tools like CiteSpace, VOSviewer, and Biblioshiny for analysis. Discussion highlights global research trends, hot topics, and advantages and disadvantages.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec8">
<label>2.2</label>
<title>Data analysis</title>
<p>For computational bibliometric evaluation, we employed three validated analytical frameworks: VOSviewer (v1.6.20), CiteSpace (v6.3. R1), and Bibliometrix R package (v4.1.3). The VOSviewer platform was configured to perform geospatial publication distribution profiling across geopolitical entities, institutional affiliations, and journal platforms, concurrently analyzing co-citation networks and term frequency matrices through predefined operational parameters: full-text enumeration methodology, multi-tiered weighting schema (document-based metrics for geopolitical/institutional/journal entities, citation-weighted indices for co-cited periodicals, frequency-adjusted measures for author-designated terminologies), association strength normalization protocols, and clustering criteria (resolution index&#x202F;=&#x202F;1.00, minimum node threshold&#x202F;=&#x202F;1, edge weight exclusio<italic>n</italic> =&#x202F;0). The Java-architected CiteSpace environment facilitated temporal network decomposition through chronographic segmentation (2012&#x2013;2024 with annual intervalization), g-index scaled network topology (<italic>k</italic>&#x202F;=&#x202F;14 coefficient), reference co-citation node typology, per-slice top-50 entry filtration, and Log-Likelihood Ratio clustering algorithm implementation, enabling dynamic visualization of journal-reference network architectures. The Bibliometrix R package, operating within RStudio 2023.03.1 (R v4.3.2 computational backend), executed international collaboration cartography and tripartite relationship visualization (author-keyword-journal nexus) alongside emergent term detection protocols constrained by temporal demarcation (2012&#x2013;2024 baseline), lexical inclusion thresholds (minimum frequency&#x202F;=&#x202F;5, annual term quota&#x202F;=&#x202F;3). Supplementary bibliometric indicators encompassing publication volumetrics, authorship distribution patterns, and citation trajectory analyses were processed through WPS Office&#x2019;s advanced analytical suite for graphical representation.</p>
</sec>
</sec>
<sec sec-type="results" id="sec9">
<label>3</label>
<title>Results</title>
<sec id="sec10">
<label>3.1</label>
<title>Fundamental quantitative data</title>
<p>865 articles written by 4,544 authors from 1,471 institutions in 92 countries were identified using the specified search strategy. Totaling 50,100 references from 7,138 different articles, these papers were published in 367 journals.</p>
</sec>
<sec id="sec11">
<label>3.2</label>
<title>Quantitative analysis of publications</title>
<p>To reveal the development trends of glymphatic system research in the field of NDs, we integrated literature resources from three authoritative databases: Web of Science, Scopus, and PubMed Central. After a rigorous process of deduplication and screening, we included 865 high-quality articles for in-depth analysis. Through systematic categorization of publication types, our analysis revealed that original articles (<italic>n</italic> =&#x202F;531, 61.39%) predominated over review articles (<italic>n</italic> =&#x202F;334, 38.61%), with an approximate ratio of 1.59:1. This distribution underscores the field&#x2019;s sustained emphasis on empirical investigation. From a macro-development perspective, as shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>, the number of publications in this field has shown a significant upward trend, indicating a continuous increase in research activity. Based on the changes in annual publication volume, the research development from 2012 to 2024 can be divided into four phases: the initial phase (2012&#x2013;2016), the early development phase (2017&#x2013;2019), the rapid growth phase (2020&#x2013;2023), and the current phase (2024 to present). During the initial phase, although the publication volume was low, these studies laid a crucial foundation for the in-depth exploration of the role of the glymphatic system in NDs. In the early development phase, there was a significant increase in publication volume compared to the initial phase, with an average annual output of approximately 125 articles. The rapid growth phase was characterized by a sharp increase in publication volume, with the number exceeding 150 articles in 2023. This marked acceleration reflects the growing attention from the academic community to the role of the glymphatic system in NDs. Notably, in 2024, the publication volume reached 233 articles, accounting for 40.2% of the total publications, and the growth trend shows no signs of slowing down. This trend indicates the increasing importance of the glymphatic system in NDs research, and it is anticipated that more relevant findings will be published in the future.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Annual output of research on glymphatic system in NDs from 2012 to 2024.</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Bar chart showing the total number of publications from 2012 to 2024, divided into articles and reviews. Publication numbers increase sharply, peaking at 238 in 2024. The line graph overlays show a trend of increasing publication percentage, reaching 40.2% in 2024.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec12">
<label>3.3</label>
<title>Distribution of research fields</title>
<p>The Web of Science database was utilized to analyze various research fields and identify the top 10 fields (<xref ref-type="fig" rid="fig3">Figure 3</xref>). In the study of the glymphatic system in NDs, Neuroscience (294 articles, accounting for 50.78%), Clinical Neurology (115 articles, 19.86%), and Biochemistry Molecular Biology (62 articles, 10.71%) are the primary research areas. Notably, Radiology Nuclear Medicine Medical Imaging (48 articles, 8.29%) also occupies a significant proportion. This indicates that research on the glymphatic system in NDs focuses not only on basic research and clinical translation but also on imaging assessment.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Distribution of major research fields in the study of the glymphatic system in NDs from 2012 to 2024.</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g003.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Treemap displaying research field proportions with neurology areas predominant. Neurosciences hold the largest section with 294 units, followed by Clinical Neurology with 115. Other notable fields include Biochemistry Molecular Biology, Radiology Nuclear Medicine, and Cell Biology.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec13">
<label>3.4</label>
<title>National and institutional analysis</title>
<p>In the field of glymphatic system research in NDs, a total of 865 articles were published by 1,471 different institutions across 92 countries. Based on the VOSviewer analysis platform, this study conducted a systematic quantitative analysis and visualized the research output in this field using the country of the first author as the statistical reference. The results show that the countries of the contributing authors span Asia, Europe, North America, and Australia (<xref ref-type="table" rid="tab1">Table 1</xref>; <xref ref-type="fig" rid="fig4">Figure 4A</xref>). From a global regional perspective, Asia (504 articles, 48.23%), Europe (302 articles, 28.90%), and North America (218 articles, 20.86%) have emerged as the three primary contributors to academic output in this field, a distribution pattern that closely aligns with the global landscape of scientific and economic development. At the national level, China (351 articles, 33.59%, 23,411 citations) and the United States (215 articles, 20.57%, 30,531 citations) lead the way in both publication numbers and citation impact, and both countries exhibit extensive international collaboration. Following them are Italy (80 articles, 7.66%, 1,762 citations), Japan (68 articles, 6.51%, 3,723 citations), and Denmark (54 articles, 5.17%, 13,862 citations) (<xref ref-type="table" rid="tab1">Table 1</xref>). These five countries collectively serve as the cornerstone supporting foundational research on the glymphatic system in NDs. To enhance analytical precision, we established a publication threshold of &#x2265;5 per country and consolidated synonymous entries, generating a collaborative network visualization comprising 19 countries to delineate both research productivity and inter-country partnership patterns (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Within this analytical framework, the size of each circle is proportional to a country&#x2019;s publication output in the target research field; larger circles indicate higher publication volumes. The connecting lines represent collaboration intensity, with thicker lines denoting higher cooperation frequency. For instance, China, which has the largest publication volume, maintains strong research collaborations with the United States, the United Kingdom, Australia, and Netherlands. Meanwhile, the United States primarily engages in extensive cooperation with the China, Denmark, the United Kingdom, and South Korea. It is noteworthy that the countries participating in the international collaboration network are primarily developed countries (<xref ref-type="table" rid="tab1">Table 1</xref>). In addition, we have also compiled statistics on the top 20 institutions by publication volume, with Chinese universities consolidated into a single group (<xref ref-type="table" rid="tab2">Table 2</xref>). Overall, the group of Chinese universities has published the largest number of articles (109 articles, 30.70%). At the level of individual institutions, the University of Rochester in the United States ranks first with 38 published articles (accounting for 10.70%) and an impressive citation count of 11,989. This is followed by the University of Copenhagen in Denmark (22 articles, 6.20%) and Oregon Health &#x0026; Science University in the United States (17 articles, 4.79%). To further refine our investigation, we applied a publication threshold of &#x2265;6 articles and selected 33 institutions from the initial 1,471 candidates. The data have been incorporated into a network visualization to illustrate the productivity and collaborative connections among institutions (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In this diagram, the diameter of the circles is proportional to the output of each institution, with larger circles indicating greater output. It is evident that the Chinese university group makes the largest overall contribution, while among individual institutions, the University of Rochester has the highest output and citation frequency. The lines connecting circles are weighted according to the frequency of collaboration between institutions&#x2014;thicker lines indicate closer and more frequent collaboration. For example, particularly close partnerships exist between the Chinese university group, the University of Rochester, and Oregon Health &#x0026; Science University. The University of Rochester and the University of Copenhagen also maintain strong cooperative ties. Notably, some institutions such as Massachusetts General Hospital and Eindhoven University of Technology have each published five or more articles, but have yet to establish significant collaborations with the core institutions in the field of glymphatic system and NDs research. With the increasing diversity of international collaborations and the rise of cross-border cooperation, communication and collaborative efforts among research institutions are expected to further intensify in the future.</p>
<table-wrap position="float" id="tab1">
<label>Table 1</label>
<caption>
<p>Country ranking by publication frequency.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Continents</th>
<th align="center" valign="top">Country</th>
<th align="center" valign="top">Counts</th>
<th align="center" valign="top">Citations</th>
<th align="center" valign="top">Total link strength</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="8">Asia (504,48.23%)</td>
<td align="center" valign="middle">China</td>
<td align="center" valign="middle">351 (33.59%)</td>
<td align="center" valign="middle">23,411</td>
<td align="center" valign="middle">26,309</td>
</tr>
<tr>
<td align="center" valign="middle">Japan</td>
<td align="center" valign="middle">68 (6.51%)</td>
<td align="center" valign="middle">3,723</td>
<td align="center" valign="middle">4,767</td>
</tr>
<tr>
<td align="center" valign="middle">South Korea</td>
<td align="center" valign="middle">49 (4.69%)</td>
<td align="center" valign="middle">1852</td>
<td align="center" valign="middle">2,343</td>
</tr>
<tr>
<td align="center" valign="middle">Iran</td>
<td align="center" valign="middle">20 (1.91%)</td>
<td align="center" valign="middle">505</td>
<td align="center" valign="middle">1,439</td>
</tr>
<tr>
<td align="center" valign="middle">Pakistan</td>
<td align="center" valign="middle">6 (0.57%)</td>
<td align="center" valign="middle">97</td>
<td align="center" valign="middle">420</td>
</tr>
<tr>
<td align="center" valign="middle">Indonesia</td>
<td align="center" valign="middle">4 (0.38%)</td>
<td align="center" valign="middle">155</td>
<td align="center" valign="middle">246</td>
</tr>
<tr>
<td align="center" valign="middle">Turkey</td>
<td align="center" valign="middle">3 (0.29%)</td>
<td align="center" valign="middle">6</td>
<td align="center" valign="middle">155</td>
</tr>
<tr>
<td align="center" valign="middle">India</td>
<td align="center" valign="middle">3 (0.29%)</td>
<td align="center" valign="middle">71</td>
<td align="center" valign="middle">148</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="18">Europe (302,28.90%)</td>
<td align="center" valign="middle">Italy</td>
<td align="center" valign="middle">80 (7.66%)</td>
<td align="center" valign="middle">1762</td>
<td align="center" valign="middle">4,888</td>
</tr>
<tr>
<td align="center" valign="middle">Denmark</td>
<td align="center" valign="middle">54 (5.17%)</td>
<td align="center" valign="middle">13,862</td>
<td align="center" valign="middle">6,021</td>
</tr>
<tr>
<td align="center" valign="middle">Norway</td>
<td align="center" valign="middle">32 (3.06%)</td>
<td align="center" valign="middle">4,756</td>
<td align="center" valign="middle">2,781</td>
</tr>
<tr>
<td align="center" valign="middle">Netherlands</td>
<td align="center" valign="middle">32 (3.06%)</td>
<td align="center" valign="middle">376</td>
<td align="center" valign="middle">1,455</td>
</tr>
<tr>
<td align="center" valign="middle">United Kingdom</td>
<td align="center" valign="middle">29 (2.78%)</td>
<td align="center" valign="middle">1847</td>
<td align="center" valign="middle">2,543</td>
</tr>
<tr>
<td align="center" valign="middle">Finland</td>
<td align="center" valign="middle">12 (1.15%)</td>
<td align="center" valign="middle">1,274</td>
<td align="center" valign="middle">831</td>
</tr>
<tr>
<td align="center" valign="middle">Poland</td>
<td align="center" valign="middle">9 (0.86%)</td>
<td align="center" valign="middle">118</td>
<td align="center" valign="middle">914</td>
</tr>
<tr>
<td align="center" valign="middle">Sweden</td>
<td align="center" valign="middle">7 (0.67%)</td>
<td align="center" valign="middle">40</td>
<td align="center" valign="middle">714</td>
</tr>
<tr>
<td align="center" valign="middle">Spain</td>
<td align="center" valign="middle">7 (0.67%)</td>
<td align="center" valign="middle">58</td>
<td align="center" valign="middle">254</td>
</tr>
<tr>
<td align="center" valign="middle">Belgium</td>
<td align="center" valign="middle">7 (0.67%)</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">143</td>
</tr>
<tr>
<td align="center" valign="middle">Switzerland</td>
<td align="center" valign="middle">6 (0.57%)</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">146</td>
</tr>
<tr>
<td align="center" valign="middle">Germany</td>
<td align="center" valign="middle">6 (0.57%)</td>
<td align="center" valign="middle">33</td>
<td align="center" valign="middle">71</td>
</tr>
<tr>
<td align="center" valign="middle">France</td>
<td align="center" valign="middle">5 (0.48%)</td>
<td align="center" valign="middle">58</td>
<td align="center" valign="middle">122</td>
</tr>
<tr>
<td align="center" valign="middle">Greece</td>
<td align="center" valign="middle">4 (0.38%)</td>
<td align="center" valign="middle">95</td>
<td align="center" valign="middle">274</td>
</tr>
<tr>
<td align="center" valign="middle">Russia</td>
<td align="center" valign="middle">3 (0.29%)</td>
<td align="center" valign="middle">41</td>
<td align="center" valign="middle">41</td>
</tr>
<tr>
<td align="center" valign="middle">Ireland</td>
<td align="center" valign="middle">3 (0.29%)</td>
<td align="center" valign="middle">94</td>
<td align="center" valign="middle">180</td>
</tr>
<tr>
<td align="center" valign="middle">Hungary</td>
<td align="center" valign="middle">3 (0.29%)</td>
<td align="center" valign="middle">109</td>
<td align="center" valign="middle">116</td>
</tr>
<tr>
<td align="center" valign="middle">Austria</td>
<td align="center" valign="middle">3 (0.29%)</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">36</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="2">North America (218,20.86%)</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">215 (20.57%)</td>
<td align="center" valign="middle">30,531</td>
<td align="center" valign="middle">18,783</td>
</tr>
<tr>
<td align="center" valign="middle">Canada</td>
<td align="center" valign="middle">3 (0.29%)</td>
<td align="center" valign="middle">706</td>
<td align="center" valign="middle">361</td>
</tr>
<tr>
<td align="left" valign="middle">Australia (21,2.01%)</td>
<td align="center" valign="middle">Australia</td>
<td align="center" valign="middle">21 (2.01%)</td>
<td align="center" valign="middle">994</td>
<td align="center" valign="middle">1,576</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p><bold>(A)</bold> World map and the number of publications in the four major continents; <bold>(B)</bold> National visualization analysis of glymphatic system in NDs; <bold>(C)</bold> Institutional visualization analysis of glymphatic system in NDs.</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g004.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Map and chart showing global scientific production data. Map indicates scientific production by country with shades of blue. Pie chart represents scientific production distribution: Asia (48.23%), Europe (28.90%), North America (20.86%), Australia (2.01%). Node graph displays international scientific collaboration: United States, China, Denmark, and others are connected, showing collaboration intensity and network between countries. Network visualization showing relationships among universities and institutions. Central nodes include "Chinese universities," "Univ Rochester," and "UCL," with interconnected lines indicating collaboration. Node size varies, reflecting network prominence. Labeled nodes include "Univ Copenhagen," "Harvard Med Sch," and "Monash Univ." The layout presents a web-like structure with distinct colored clusters on a dark background.</alt-text>
</graphic>
</fig>
<table-wrap position="float" id="tab2">
<label>Table 2</label>
<caption>
<p>Ranking of top 20 organizations based on publication frequency.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="center" valign="top">Organization</th>
<th align="center" valign="top">Country</th>
<th align="center" valign="top">Counts</th>
<th align="center" valign="top">Citations</th>
<th align="center" valign="top">Total link strength</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">Chinese Universities</td>
<td align="center" valign="middle">China</td>
<td align="center" valign="middle">109 (30.70%)</td>
<td align="center" valign="middle">8,268</td>
<td align="center" valign="middle">66</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">University of Rochester</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">38 (10.70%)</td>
<td align="center" valign="middle">11,989</td>
<td align="center" valign="middle">73</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">University of Copenhagen</td>
<td align="center" valign="middle">Denmark</td>
<td align="center" valign="middle">22 (6.20%)</td>
<td align="center" valign="middle">3,693</td>
<td align="center" valign="middle">45</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="center" valign="middle">Oregon Health and Science University</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">17 (4.79%)</td>
<td align="center" valign="middle">3,207</td>
<td align="center" valign="middle">14</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="center" valign="middle">University College London</td>
<td align="center" valign="middle">United Kingdom</td>
<td align="center" valign="middle">16 (4.51%)</td>
<td align="center" valign="middle">607</td>
<td align="center" valign="middle">14</td>
</tr>
<tr>
<td align="left" valign="middle">6</td>
<td align="center" valign="middle">Nagoya University</td>
<td align="center" valign="middle">Japan</td>
<td align="center" valign="middle">13 (3.66%)</td>
<td align="center" valign="middle">1,063</td>
<td align="center" valign="middle">7</td>
</tr>
<tr>
<td align="left" valign="middle">7</td>
<td align="center" valign="middle">Yale School of Medicine</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">13 (3.66%)</td>
<td align="center" valign="middle">619</td>
<td align="center" valign="middle">9</td>
</tr>
<tr>
<td align="left" valign="middle">8</td>
<td align="center" valign="middle">University of Oslo</td>
<td align="center" valign="middle">Norway</td>
<td align="center" valign="middle">12 (3.38%)</td>
<td align="center" valign="middle">3,847</td>
<td align="center" valign="middle">24</td>
</tr>
<tr>
<td align="left" valign="middle">9</td>
<td align="center" valign="middle">Lund University</td>
<td align="center" valign="middle">Sweden</td>
<td align="center" valign="middle">12 (3.38%)</td>
<td align="center" valign="middle">930</td>
<td align="center" valign="middle">20</td>
</tr>
<tr>
<td align="left" valign="middle">10</td>
<td align="center" valign="middle">Harvard Medical School</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">11 (3.10%)</td>
<td align="center" valign="middle">552</td>
<td align="center" valign="middle">20</td>
</tr>
<tr>
<td align="left" valign="middle">11</td>
<td align="center" valign="middle">University of Southern California</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">11 (3.10%)</td>
<td align="center" valign="middle">716</td>
<td align="center" valign="middle">9</td>
</tr>
<tr>
<td align="left" valign="middle">12</td>
<td align="center" valign="middle">University of Washington</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">11 (3.10%)</td>
<td align="center" valign="middle">625</td>
<td align="center" valign="middle">26</td>
</tr>
<tr>
<td align="left" valign="middle">13</td>
<td align="center" valign="middle">Monash University</td>
<td align="center" valign="middle">Australia</td>
<td align="center" valign="middle">10 (2.82%)</td>
<td align="center" valign="middle">367</td>
<td align="center" valign="middle">7</td>
</tr>
<tr>
<td align="left" valign="middle">14</td>
<td align="center" valign="middle">University of Copenhagen</td>
<td align="center" valign="middle">Denmark</td>
<td align="center" valign="middle">10 (2.82%)</td>
<td align="center" valign="middle">561</td>
<td align="center" valign="middle">11</td>
</tr>
<tr>
<td align="left" valign="middle">15</td>
<td align="center" valign="middle">University of Rochester Medical Center</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">10 (2.82%)</td>
<td align="center" valign="middle">197</td>
<td align="center" valign="middle">4</td>
</tr>
<tr>
<td align="left" valign="middle">16</td>
<td align="center" valign="middle">State University of New York at Stony Brook</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">9 (2.54%)</td>
<td align="center" valign="middle">5,135</td>
<td align="center" valign="middle">30</td>
</tr>
<tr>
<td align="left" valign="middle">17</td>
<td align="center" valign="middle">University of Toronto</td>
<td align="center" valign="middle">Canada</td>
<td align="center" valign="middle">8 (2.25%)</td>
<td align="center" valign="middle">797</td>
<td align="center" valign="middle">7</td>
</tr>
<tr>
<td align="left" valign="middle">18</td>
<td align="center" valign="middle">Johns Hopkins University</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">8 (2.25%)</td>
<td align="center" valign="middle">111</td>
<td align="center" valign="middle">7</td>
</tr>
<tr>
<td align="left" valign="middle">19</td>
<td align="center" valign="middle">University of Kentucky</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">8 (2.25%)</td>
<td align="center" valign="middle">753</td>
<td align="center" valign="middle">8</td>
</tr>
<tr>
<td align="left" valign="middle">20</td>
<td align="center" valign="middle">Eindhoven University of Technology</td>
<td align="center" valign="middle">Netherlands</td>
<td align="center" valign="middle">7 (1.97%)</td>
<td align="center" valign="middle">1,589</td>
<td align="center" valign="middle">26</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec14">
<label>3.5</label>
<title>Journals and co-cited journals analysis</title>
<p>VOSviewer was employed to analyze journals and co-cited journals (<xref ref-type="table" rid="tab3">Table 3</xref>). The analysis revealed that a total of 865 articles were published across 367 distinct academic journals. This paper presents the top 10 journals ranked by publication count. After consolidating the Frontiers series of journals, they merged them into a more cohesive and strategically significant core category&#x2014;<italic>Frontiers.</italic> Within this new category, Frontiers tops the overall ranking in terms of publication volume, with 68 articles accounting for 31.3%. Among these, <italic>Frontiers in Aging Neuroscience</italic> (22 articles, 10.1%) and <italic>Frontiers in Neuroscience</italic> (21 articles, 9.7%) have played pivotal roles, emerging as the primary drivers of this success. They are followed by the <italic>International Journal of Molecular Sciences</italic> (29 articles, 13.4%), <italic>the Journal of Alzheimer&#x2019;s Disease</italic> (21 articles, 9.7%), and <italic>the Journal of Cerebral Blood Flow and Metabolism</italic> (18 articles, 8.3%). The Journal Citation Reports (JCR), developed by Thomson Reuters, is an important metric for assessing the quality of academic journals. JCR categorizes journals into 176 different subject categories and ranks them into Q1, Q2, Q3, and Q4 based on their impact factors (<xref ref-type="bibr" rid="ref33">Liu et al., 2024a</xref>). Among the top 10 journals, all but <italic>Frontiers in Pharmacology</italic> and <italic>Frontiers in Immunology</italic> published more than 10 papers. Moreover, the majority of these journals are listed in the Q1 section of JCR. Hirsch developed the h-index to assess a journal&#x2019;s impact on citations and productivity (<xref ref-type="bibr" rid="ref24">Hirsch, 2005</xref>). In order to reflect the journal&#x2019;s importance in the area, the h-index calculates the number of papers (h) that have been referenced at least h times (<xref ref-type="bibr" rid="ref25">Hou et al., 2022</xref>). According to <xref ref-type="table" rid="tab2">Table 2</xref>, <italic>Neuroimage</italic> has the greatest h-index (H-index: 320), followed by Brain (H-index: 308). Among these journals, <italic>Frontiers</italic> leads in total citations (1,112 times), followed by <italic>Brain</italic> (986 times) and the <italic>Journal of Cerebral Blood Flow and Metabolism</italic> (749 times). Additionally, <italic>Brain</italic> has the highest impact factor (IF&#x202F;=&#x202F;11.9) among these journals. Among the top 10 co-cited journals, <italic>the Journal of Neuroscience</italic> was cited 1,601 times, ranking first, followed by <italic>Science</italic> (1,575 times) and <italic>Nature</italic> (1,367 times). Co-cited journals refer to journals that are cited together in the reference lists of two or more academic publications. If two journals are frequently cited together in the same set of papers, a co-citation relationship exists between them. Analyzing co-cited journals can reveal academic connections between journals, the developmental trajectory of research fields, and the intellectual structure of disciplines. Nine out of the top 10 co-cited journals belong to the Q1 JCR division, with Nature having the highest IF (IF&#x202F;=&#x202F;50.5). A density map can visually display journals and co-cited journals (<xref ref-type="fig" rid="fig5">Figure 5</xref>). Journal overlay maps can visually show the distribution of journals across disciplines; the first map is an overlay of citing journals (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), and the second is an overlay of cited journals (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). We found that the dual map overlay of journals can visually display the distribution of journals across disciplines and the evolution of citation trajectories. The distribution of journals and the connection between citing and cited journals are accurately depicted by the dual map coverage of journals in <xref ref-type="fig" rid="fig6">Figure 6C</xref>. Citation associations are indicated by the colored paths. Citing journals are displayed on the left map, and cited journals are displayed on the right map. Three primary reference paths are shown (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). According to the current study, articles from the magazine &#x201C;Molecular/Biology/Genetics&#x201D; were frequently referenced by &#x201C;Molecular/Biology/Immunology&#x201D; and &#x201C;Neurology/Sports/Ophthalmology.&#x201D; Additionally, &#x201C;Molecular/Biology/Immunology&#x201D; frequently cited articles from the magazine &#x201C;Psychology/Education/Social.&#x201D;</p>
<table-wrap position="float" id="tab3">
<label>Table 3</label>
<caption>
<p>Top 10 most productive journals and co-cited journals: comparative analysis of publication output and citation impact.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="center" valign="top">Journals</th>
<th align="center" valign="top">Counts</th>
<th align="center" valign="top">Citations</th>
<th align="center" valign="top">JCR (IF)<break/>(2023)</th>
<th align="center" valign="top">H-index</th>
<th align="center" valign="top">Rank</th>
<th align="center" valign="top">Co-cited journals</th>
<th align="center" valign="top">Citations</th>
<th align="center" valign="top">JCR (IF)<break/>(2023)</th>
<th align="center" valign="top">H-index</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="6">1</td>
<td align="center" valign="middle">Frontiers series (total)</td>
<td align="center" valign="middle">68 (31.3%)</td>
<td align="center" valign="middle">/</td>
<td align="center" valign="middle">/</td>
<td align="center" valign="middle">/</td>
<td align="center" valign="middle" rowspan="6">1</td>
<td align="center" valign="middle" rowspan="6">Journal of neuroscience</td>
<td align="center" valign="middle" rowspan="6">1,601</td>
<td align="center" valign="middle" rowspan="6">Q1 (4.4)</td>
<td align="center" valign="middle" rowspan="6">422</td>
</tr>
<tr>
<td align="center" valign="middle">frontiers in aging neuroscience</td>
<td align="center" valign="middle">22 (10.1%)</td>
<td align="center" valign="middle">369</td>
<td align="center" valign="middle">Q2 (4.1)</td>
<td align="center" valign="middle">120</td>
</tr>
<tr>
<td align="center" valign="middle">frontiers in neuroscience</td>
<td align="center" valign="middle">21 (9.7%)</td>
<td align="center" valign="middle">339</td>
<td align="center" valign="middle">Q2 (3.2)</td>
<td align="center" valign="middle">153</td>
</tr>
<tr>
<td align="center" valign="middle">frontiers in neurology</td>
<td align="center" valign="middle">14 (6.5%)</td>
<td align="center" valign="middle">139</td>
<td align="center" valign="middle">Q3 (2.7)</td>
<td align="center" valign="middle">105</td>
</tr>
<tr>
<td align="center" valign="middle">frontiers in pharmacology</td>
<td align="center" valign="middle">6 (2.8%)</td>
<td align="center" valign="middle">247</td>
<td align="center" valign="middle">Q1 (4.4)</td>
<td align="center" valign="middle">62</td>
</tr>
<tr>
<td align="center" valign="middle">frontiers in immunology</td>
<td align="center" valign="middle">5 (2.3%)</td>
<td align="center" valign="middle">18</td>
<td align="center" valign="middle">Q1 (5.7)</td>
<td align="center" valign="middle">155</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">International journal of molecular sciences</td>
<td align="center" valign="middle">29 (13.4%)</td>
<td align="center" valign="middle">432</td>
<td align="center" valign="middle">Q1 (4.9)</td>
<td align="center" valign="middle">114</td>
<td align="center" valign="middle">2</td>
<td align="center" valign="middle">Science</td>
<td align="center" valign="middle">1,575</td>
<td align="center" valign="middle">Q1 (44.8)</td>
<td align="center" valign="middle">1,058</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">Journal of Alzheimers disease</td>
<td align="center" valign="middle">21 (9.7%)</td>
<td align="center" valign="middle">447</td>
<td align="center" valign="middle">Q2 (3.4)</td>
<td align="center" valign="middle">115</td>
<td align="center" valign="middle">3</td>
<td align="center" valign="middle">Nature</td>
<td align="center" valign="middle">1,367</td>
<td align="center" valign="middle">Q1 (50.5)</td>
<td align="center" valign="middle">1,096</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="center" valign="middle">Journal of cerebral blood flow and metabolism</td>
<td align="center" valign="middle">18 (8.3%)</td>
<td align="center" valign="middle">749</td>
<td align="center" valign="middle">Q1 (4.9)</td>
<td align="center" valign="middle">177</td>
<td align="center" valign="middle">4</td>
<td align="center" valign="middle">Neurology</td>
<td align="center" valign="middle">1,316</td>
<td align="center" valign="middle">Q1 (8.4)</td>
<td align="center" valign="middle">331</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="center" valign="middle">Scientific reports</td>
<td align="center" valign="middle">16 (7.4%)</td>
<td align="center" valign="middle">375</td>
<td align="center" valign="middle">Q1 (3.8)</td>
<td align="center" valign="middle">149</td>
<td align="center" valign="middle">5</td>
<td align="center" valign="middle">Brain</td>
<td align="center" valign="middle">1,315</td>
<td align="center" valign="middle">Q1 (11.9)</td>
<td align="center" valign="middle">308</td>
</tr>
<tr>
<td align="left" valign="middle">6</td>
<td align="center" valign="middle">Fluids and barriers of the cns</td>
<td align="center" valign="middle">16 (7.4%)</td>
<td align="center" valign="middle">120</td>
<td align="center" valign="middle">Q1 (5.9)</td>
<td align="center" valign="middle">65</td>
<td align="center" valign="middle">6</td>
<td align="center" valign="middle">Journal of Alzheimers disease</td>
<td align="center" valign="middle">823</td>
<td align="center" valign="middle">Q2 (3.4)</td>
<td align="center" valign="middle">115</td>
</tr>
<tr>
<td align="left" valign="middle">7</td>
<td align="center" valign="middle">Brain</td>
<td align="center" valign="middle">14 (6.5%)</td>
<td align="center" valign="middle">986</td>
<td align="center" valign="middle">Q1 (11.9)</td>
<td align="center" valign="middle">308</td>
<td align="center" valign="middle">7</td>
<td align="center" valign="middle">Neuron</td>
<td align="center" valign="middle">930</td>
<td align="center" valign="middle">Q1 (16.2)</td>
<td align="center" valign="middle">530</td>
</tr>
<tr>
<td align="left" valign="middle">8</td>
<td align="center" valign="middle">Neurobiology of disease</td>
<td align="center" valign="middle">12 (5.5%)</td>
<td align="center" valign="middle">587</td>
<td align="center" valign="middle">Q1 (5.1)</td>
<td align="center" valign="middle">151</td>
<td align="center" valign="middle">8</td>
<td align="center" valign="middle">Neuroimage</td>
<td align="center" valign="middle">924</td>
<td align="center" valign="middle">Q1 (4.7)</td>
<td align="center" valign="middle">320</td>
</tr>
<tr>
<td align="left" valign="middle">9</td>
<td align="center" valign="middle">Neuroimage</td>
<td align="center" valign="middle">12 (5.5%)</td>
<td align="center" valign="middle">268</td>
<td align="center" valign="middle">Q1 (4.7)</td>
<td align="center" valign="middle">320</td>
<td align="center" valign="middle">9</td>
<td align="center" valign="middle">Annals of neurology</td>
<td align="center" valign="middle">907</td>
<td align="center" valign="middle">Q1 (8.1)</td>
<td align="center" valign="middle">273</td>
</tr>
<tr>
<td align="left" valign="middle">10</td>
<td align="center" valign="middle">Brain sciences</td>
<td align="center" valign="middle">11 (5.1%)</td>
<td align="center" valign="middle">185</td>
<td align="center" valign="middle">Q1 (5.1)</td>
<td align="center" valign="middle">151</td>
<td align="center" valign="middle">10</td>
<td align="center" valign="middle">Journal of cerebral blood flow and metabolism</td>
<td align="center" valign="middle">830</td>
<td align="center" valign="middle">Q1 (4.9)</td>
<td align="center" valign="middle">177</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>Density map of journals associated with glymphatic system research in NDs; <bold>(A)</bold> Depicts periodicals meeting a threshold of &#x2265;5 published articles (35 journals collectively); <bold>(B)</bold> Includes co-cited journals with &#x2265;150 citations (79 journals aggregately).</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g005.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Two density maps labeled A and B show clusters of journal names with varying prominence. In the top map (A), "frontiers" and "international journal of molec" are central. In the bottom map (B), "nature", "neuron", and "j neurosci" are central with a denser concentration of names around them. The maps visualize the connections and importance of different journals in a scholarly context.</alt-text>
</graphic>
</fig>
<fig position="float" id="fig6">
<label>Figure 6</label>
<caption>
<p><bold>(A)</bold> The map overlay of citing journals regarding the glymphatic system in NDs; <bold>(B)</bold> The map overlay of cited journals regarding the glymphatic system in NDs; <bold>(C)</bold> Journal double-figure overlay of glymphatic system in NDs.</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g006.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Two network visualizations labeled A and B generated by VOSviewer. Clusters of nodes represent academic journals and their relationships based on citation data. Nodes are color-coded, indicating different clusters or research fields. Density and proximity of nodes suggest the interconnectedness of these journals. Colorful network diagram with nodes and curved lines connecting various scientific disciplines, such as physics, ecology, and medicine. Each node is labeled, representing research categories. Flow lines indicate relationships between fields, forming a complex, intertwined network on a dark background.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec15">
<label>3.6</label>
<title>Authors and co-cited authors analysis</title>
<p>Co-cited authors refer to two or more authors being simultaneously cited by others or multiple papers, establishing a co-citation relationship. In <xref ref-type="fig" rid="fig7">Figures 7a</xref>,<xref ref-type="fig" rid="fig7">B</xref>, each node represents an author or co-cited author, with node size proportional to the number of publications or citation frequency. The connecting lines between nodes indicate the degree of collaboration between authors or co-cited authors, where thicker lines denote stronger collaborative ties. Nodes sharing the same color form a cluster. Denser and more extensive connections between two clusters signify closer collaboration. As shown in <xref ref-type="fig" rid="fig7">Figures 7a</xref>,<xref ref-type="fig" rid="fig7">B</xref>, authors and co-cited authors are distributed across several distinct clusters, with those within the same cluster demonstrating closer relationships. Furthermore, we first grouped all Chinese authors into a single &#x201C;Chinese authors group,&#x201D; which includes authors from an internally well-known Chinese research group. Utilizing VOSviewer, we incorporated 153 authors with more than three published articles into the authors&#x2019; network. Analysis of the top 20 most influential authors worldwide revealed that the Chinese authors (351 articles, 61.69%, 23,411 citations) ranked first in terms of publication count, citation frequency, and total link strength. However, deeper examination of their academic output structure shows a predominant focus on original articles (86.32%), with review articles constituting only 13.68%. This output pattern contrasts sharply with their impact metrics: despite commanding a substantial lead in total output, their citations per paper stand at just 66.70. In comparison, Denmark&#x2019;s Nedergaard M., while producing a smaller total output (45 articles), exhibits exceptional academic influence. With 11,995 cumulative citations and a total link strength of 5,111, their citations per paper reach 266.56, which is four times that of the Chinese authors. Notably, U. S. scholar Rashid Deane leads globally with 920.17 citations per paper, while the Nedergaard M.&#x2019;s impact remains remarkable. Further analysis reveals the Nedergaard M. maintains a more balanced publication portfolio, with review articles accounting for 26.67% of their output&#x2014;nearly double the Chinese authors&#x2019; proportion (<xref ref-type="table" rid="tab4">Table 4</xref>). These differences are visually captured in the bubble chart (<xref ref-type="fig" rid="fig7">Figures 7A</xref>,<xref ref-type="fig" rid="fig7">b</xref>): the Chinese authors cluster in the &#x201C;high-original/low-impact&#x201D; quadrant (coordinates: X&#x202F;=&#x202F;13.68%, Y&#x202F;=&#x202F;86.32%), while the Nedergaard M. occupies the &#x201C;balanced/high-impact&#x201D; region (coordinates: X&#x202F;=&#x202F;26.67%, Y&#x202F;=&#x202F;73.33%). The bubble area (representing citations per paper) shows a four-fold difference between teams. <xref ref-type="table" rid="tab4">Table 4</xref> multidimensional comparative analysis quantifies these findings: the Chinese authors exemplify a &#x201C;quantity-driven/original-focused&#x201D; model, whereas the Nedergaard M. embodies a &#x201C;quality-first/balanced-development&#x201D; approach. To further analyze the situation of co-cited authors, we also combined all cited Chinese authors as &#x201C;Co-cited Chinese authors.&#x201D; A total of 79 authors who had been cited more than 50 times were selected to construct the co-citation network, from which the top 20 most frequently co-cited authors were identified for cluster analysis. The results indicated that all of these authors had been cited more than 150 citations. In Asia, the &#x201C;Co-cited Chinese authors&#x201D; had the highest total citations (3,271 citations) and the highest total link strength (112,789 TLS). Notably, Iliff, J. J. from the United States was the most frequently co-cited author (1,108 citations) with the highest total link strength (33,911 TLS), highlighting his significant academic impact and collaborative ties in the study of the glymphatic system in NDs (<xref ref-type="table" rid="tab5">Table 5</xref>).</p>
<fig position="float" id="fig7">
<label>Figure 7</label>
<caption>
<p><bold>(A) (a)</bold> A VOSviewer-generated mapping framework depicting authors contributing to glymphatic system investigations in NDs; <bold>(b)</bold> Comparative analysis of publication impact between high-productivity Chinese authors and the Nedergaard M (bubble chart: X, review proportion; Y, article proportion; bubble size, citations per paper); <bold>(B)</bold> A VOSviewer-generated mapping framework depicting co-authors contributing to glymphatic system investigations in NDs.</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g007.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Diagram A consists of two visuals: (a) a network map with nodes and connecting lines displaying relationships among "Chinese authors" and various researchers, color-coded by clusters, and (b) a bubble chart showing "Chinese authors" and "Nedergaard, maiken" with axes labeled "Article proportion" and "Review proportion". Diagram B is a network map showing "co-cited Chinese authors" with connections to other researchers, highlighted with various colors indicating different clusters.</alt-text>
</graphic>
</fig>
<table-wrap position="float" id="tab4">
<label>Table 4</label>
<caption>
<p>Top 20 authors and collaborative citations on glymphatic system in NDs.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Continents</th>
<th align="center" valign="top">Author</th>
<th align="center" valign="top">Country</th>
<th align="center" valign="top">Counts</th>
<th align="center" valign="top">Citations</th>
<th align="center" valign="top">Citations per paper</th>
<th align="center" valign="top">Original article</th>
<th align="center" valign="top">Review article</th>
<th align="center" valign="top">Total link strength</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="5">Asia (390,68.54%)</td>
<td align="center" valign="middle">Chinese authors</td>
<td align="center" valign="middle">China</td>
<td align="center" valign="middle">351 (61.69%)</td>
<td align="center" valign="middle">23,411</td>
<td align="center" valign="middle">66.70</td>
<td align="center" valign="middle">303 (86.32%)</td>
<td align="center" valign="middle">48 (13.68%)</td>
<td align="center" valign="middle">26,309</td>
</tr>
<tr>
<td align="center" valign="middle">Taoka, Toshiaki</td>
<td align="center" valign="middle">Japan</td>
<td align="center" valign="middle">12 (2.11%)</td>
<td align="center" valign="middle">1,006</td>
<td align="center" valign="middle">83.83</td>
<td align="center" valign="middle">7 (58.33%)</td>
<td align="center" valign="middle">5 (41.67%)</td>
<td align="center" valign="middle">1,149</td>
</tr>
<tr>
<td align="center" valign="middle">Lee, Hedok</td>
<td align="center" valign="middle">South Korea</td>
<td align="center" valign="middle">9 (1.58%)</td>
<td align="center" valign="middle">1,602</td>
<td align="center" valign="middle">178.00</td>
<td align="center" valign="middle">6 (66.67%)</td>
<td align="center" valign="middle">3 (33.33%)</td>
<td align="center" valign="middle">906</td>
</tr>
<tr>
<td align="center" valign="middle">Naganawa, Shinji</td>
<td align="center" valign="middle">Japan</td>
<td align="center" valign="middle">9 (1.58%)</td>
<td align="center" valign="middle">838</td>
<td align="center" valign="middle">93.11</td>
<td align="center" valign="middle">4 (44.44%)</td>
<td align="center" valign="middle">5 (55.55%)</td>
<td align="center" valign="middle">891</td>
</tr>
<tr>
<td align="center" valign="middle">Choupan, Jeiran</td>
<td align="center" valign="middle">Iran</td>
<td align="center" valign="middle">9 (1.58%)</td>
<td align="center" valign="middle">78</td>
<td align="center" valign="middle">8.67</td>
<td align="center" valign="middle">8 (88.89%)</td>
<td align="center" valign="middle">1 (11.11%)</td>
<td align="center" valign="middle">372</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="10">North America (98,17.22%)</td>
<td align="center" valign="middle">Iliff, Jeffrey J.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">25 (4.39%)</td>
<td align="center" valign="middle">7,234</td>
<td align="center" valign="middle">289.36</td>
<td align="center" valign="middle">19 (76.00%)</td>
<td align="center" valign="middle">6 (24.00%)</td>
<td align="center" valign="middle">3,173</td>
</tr>
<tr>
<td align="center" valign="middle">Benveniste, Helene</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">18 (3.16%)</td>
<td align="center" valign="middle">5,854</td>
<td align="center" valign="middle">325.22</td>
<td align="center" valign="middle">13 (72.22%)</td>
<td align="center" valign="middle">5 (27.78%)</td>
<td align="center" valign="middle">2,325</td>
</tr>
<tr>
<td align="center" valign="middle">De Leon, Mony J.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">8 (1.41%)</td>
<td align="center" valign="middle">93</td>
<td align="center" valign="middle">11.63</td>
<td align="center" valign="middle">6 (75.00%)</td>
<td align="center" valign="middle">2 (25.00%)</td>
<td align="center" valign="middle">614</td>
</tr>
<tr>
<td align="center" valign="middle">Kelley, Douglas H.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">8 (1.41%)</td>
<td align="center" valign="middle">291</td>
<td align="center" valign="middle">36.38</td>
<td align="center" valign="middle">6 (75.00%)</td>
<td align="center" valign="middle">2 (25.00%)</td>
<td align="center" valign="middle">490</td>
</tr>
<tr>
<td align="center" valign="middle">Mestre, Humberto</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">8 (1.41%)</td>
<td align="center" valign="middle">2,647</td>
<td align="center" valign="middle">330.88</td>
<td align="center" valign="middle">4 (50.00%)</td>
<td align="center" valign="middle">4 (50.00%)</td>
<td align="center" valign="middle">1,390</td>
</tr>
<tr>
<td align="center" valign="middle">Tannenbaum, Allen</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">7 (1.23%)</td>
<td align="center" valign="middle">780</td>
<td align="center" valign="middle">111.43</td>
<td align="center" valign="middle">3 (42.86%)</td>
<td align="center" valign="middle">4 (57.14%)</td>
<td align="center" valign="middle">618</td>
</tr>
<tr>
<td align="center" valign="middle">Chopp, Michael</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">6 (1.05%)</td>
<td align="center" valign="middle">36</td>
<td align="center" valign="middle">6.00</td>
<td align="center" valign="middle">4 (66.67%)</td>
<td align="center" valign="middle">2 (33.33%)</td>
<td align="center" valign="middle">163</td>
</tr>
<tr>
<td align="center" valign="middle">Claassen, Daniel o.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">6 (1.05%)</td>
<td align="center" valign="middle">147</td>
<td align="center" valign="middle">24.50</td>
<td align="center" valign="middle">6 (100.00%)</td>
<td align="center" valign="middle">0 (0.00%)</td>
<td align="center" valign="middle">244</td>
</tr>
<tr>
<td align="center" valign="middle">Deane, Rashid</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">6 (1.05%)</td>
<td align="center" valign="middle">5,521</td>
<td align="center" valign="middle">920.17</td>
<td align="center" valign="middle">6 (100.00%)</td>
<td align="center" valign="middle">0 (0.00%)</td>
<td align="center" valign="middle">2025</td>
</tr>
<tr>
<td align="center" valign="middle">Donahue, Manus J.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">6 (1.05%)</td>
<td align="center" valign="middle">147</td>
<td align="center" valign="middle">24.50</td>
<td align="center" valign="middle">6 (100.00%)</td>
<td align="center" valign="middle">0 (0.00%)</td>
<td align="center" valign="middle">244</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="5">Europe (81,14.24%)</td>
<td align="center" valign="middle">Nedergaard, Maiken</td>
<td align="center" valign="middle">Denmark</td>
<td align="center" valign="middle">45 (7.91%)</td>
<td align="center" valign="middle">11,995</td>
<td align="center" valign="middle">266.56</td>
<td align="center" valign="middle">33 (73.33%)</td>
<td align="center" valign="middle">12 (26.67%)</td>
<td align="center" valign="middle">5,111</td>
</tr>
<tr>
<td align="center" valign="middle">Eide, per Kristian</td>
<td align="center" valign="middle">Norway</td>
<td align="center" valign="middle">10 (1.76%)</td>
<td align="center" valign="middle">673</td>
<td align="center" valign="middle">67.30</td>
<td align="center" valign="middle">8 (80.00%)</td>
<td align="center" valign="middle">2 (20.00%)</td>
<td align="center" valign="middle">570</td>
</tr>
<tr>
<td align="center" valign="middle">Ringstad, Geir</td>
<td align="center" valign="middle">Norway</td>
<td align="center" valign="middle">10 (1.76%)</td>
<td align="center" valign="middle">665</td>
<td align="center" valign="middle">66.50</td>
<td align="center" valign="middle">7 (70.00%)</td>
<td align="center" valign="middle">3 (30.00%)</td>
<td align="center" valign="middle">687</td>
</tr>
<tr>
<td align="center" valign="middle">Lundgaard, Iben</td>
<td align="center" valign="middle">Denmark</td>
<td align="center" valign="middle">9 (1.58%)</td>
<td align="center" valign="middle">1867</td>
<td align="center" valign="middle">207.44</td>
<td align="center" valign="middle">5 (55.56%)</td>
<td align="center" valign="middle">4 (44.44%)</td>
<td align="center" valign="middle">910</td>
</tr>
<tr>
<td align="center" valign="middle">Wostyn, Peter</td>
<td align="center" valign="middle">Belgium</td>
<td align="center" valign="middle">7 (1.23%)</td>
<td align="center" valign="middle">0</td>
<td align="center" valign="middle">0.00</td>
<td align="center" valign="middle">4 (57.14%)</td>
<td align="center" valign="middle">3 (42.86%)</td>
<td align="center" valign="middle">143</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap position="float" id="tab5">
<label>Table 5</label>
<caption>
<p>Top 20 co-cited authors and collaborative citations on glymphatic system in NDs.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Continents</th>
<th align="center" valign="top">Co-cited author</th>
<th align="center" valign="top">country</th>
<th align="center" valign="top">Citations</th>
<th align="center" valign="top">Total link strength (TLS)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle" rowspan="3">Asia (3,784,42.53%)</td>
<td align="center" valign="middle">Co-cited Chinese authors</td>
<td align="center" valign="middle">China</td>
<td align="center" valign="middle">3,271 (36.77%)</td>
<td align="center" valign="middle">112,789</td>
</tr>
<tr>
<td align="center" valign="middle">Taoka, T.</td>
<td align="center" valign="middle">Japan</td>
<td align="center" valign="middle">353 (3.97%)</td>
<td align="center" valign="middle">12,545</td>
</tr>
<tr>
<td align="center" valign="middle">Naganawa, S.</td>
<td align="center" valign="middle">Japan</td>
<td align="center" valign="middle">160 (1.80%)</td>
<td align="center" valign="middle">7,426</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="7">North America (2,663,29.93%)</td>
<td align="center" valign="middle">Iliff, J. J.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">1,108 (12.45%)</td>
<td align="center" valign="middle">33,911</td>
</tr>
<tr>
<td align="center" valign="middle">Louveau, A.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">392 (4.41%)</td>
<td align="center" valign="middle">14,021</td>
</tr>
<tr>
<td align="center" valign="middle">Kress, B. T.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">276 (3.10%)</td>
<td align="center" valign="middle">9,602</td>
</tr>
<tr>
<td align="center" valign="middle">Da mesquita, S.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">259 (2.91%)</td>
<td align="center" valign="middle">9,506</td>
</tr>
<tr>
<td align="center" valign="middle">Hablitz, L. M.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">233 (2.62%)</td>
<td align="center" valign="middle">8,831</td>
</tr>
<tr>
<td align="center" valign="middle">Benveniste, H.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">204 (2.29%)</td>
<td align="center" valign="middle">7,948</td>
</tr>
<tr>
<td align="center" valign="middle">Plog, B. A.</td>
<td align="center" valign="middle">United States</td>
<td align="center" valign="middle">191 (2.15%)</td>
<td align="center" valign="middle">7,621</td>
</tr>
<tr>
<td align="left" valign="middle" rowspan="10">Europe (2,450,27.54%)</td>
<td align="center" valign="middle">Mestre, H.</td>
<td align="center" valign="middle">Norway</td>
<td align="center" valign="middle">475 (5.34%)</td>
<td align="center" valign="middle">18,183</td>
</tr>
<tr>
<td align="center" valign="middle">Ringstad, G.</td>
<td align="center" valign="middle">Norway</td>
<td align="center" valign="middle">288 (3.24%)</td>
<td align="center" valign="middle">11,636</td>
</tr>
<tr>
<td align="center" valign="middle">Eide, P. K.</td>
<td align="center" valign="middle">Norway</td>
<td align="center" valign="middle">277 (3.11%)</td>
<td align="center" valign="middle">12,562</td>
</tr>
<tr>
<td align="center" valign="middle">Nedergaard, M.</td>
<td align="center" valign="middle">Denmark</td>
<td align="center" valign="middle">244 (2.74%)</td>
<td align="center" valign="middle">7,982</td>
</tr>
<tr>
<td align="center" valign="middle">Rasmussen, M. K.</td>
<td align="center" valign="middle">Denmark</td>
<td align="center" valign="middle">223 (2.51%)</td>
<td align="center" valign="middle">7,395</td>
</tr>
<tr>
<td align="center" valign="middle">Wardlaw, J. M.</td>
<td align="center" valign="middle">United Kingdom</td>
<td align="center" valign="middle">219 (2.46%)</td>
<td align="center" valign="middle">7,116</td>
</tr>
<tr>
<td align="center" valign="middle">Jessen, N. A.</td>
<td align="center" valign="middle">Norway</td>
<td align="center" valign="middle">212 (2.38%)</td>
<td align="center" valign="middle">6,509</td>
</tr>
<tr>
<td align="center" valign="middle">Weller, R. O.</td>
<td align="center" valign="middle">United Kingdom</td>
<td align="center" valign="middle">186 (2.09%)</td>
<td align="center" valign="middle">6,680</td>
</tr>
<tr>
<td align="center" valign="middle">Aspelund, A.</td>
<td align="center" valign="middle">Norway</td>
<td align="center" valign="middle">174 (1.96%)</td>
<td align="center" valign="middle">6,616</td>
</tr>
<tr>
<td align="center" valign="middle">Zeppenfeld, D. M.</td>
<td align="center" valign="middle">Germany</td>
<td align="center" valign="middle">152 (1.71%)</td>
<td align="center" valign="middle">5,020</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec16">
<label>3.7</label>
<title>Co-occurrence of keywords analysis</title>
<p>Examining lexical co-occurrence, thematic clustering, and temporal evolution serves as a methodological approach to identify trending themes with rapidly evolving prominence. Visualization of these lexical patterns enables researchers to elucidate core priorities and intellectual trends within the discipline, supporting holistic comprehension of its evolutionary pathways. From a corpus of 865 publications, 5,346 distinct keywords were systematically identified through VOSviewer&#x2019;s analytical framework. Since some words, such as &#x201C;Alzheimer&#x2019;s disease&#x201D; and &#x201C;Alzheime&#x2019;s disease,&#x201D; expressed the same meaning, these synonyms were combined in the analysis. The top 20 most frequent keywords are displayed in <xref ref-type="table" rid="tab6">Table 6</xref>. The keyword analysis identified &#x201C;Glymphatic system&#x201D; (695 occurrences) and &#x201C;Alzheimer&#x2019;s disease&#x201D; (472 occurrences) as the highest-frequency terms, with subsequent prominence observed for &#x201C;Human&#x201D; (<italic>n</italic> =&#x202F;217) &#x201C;Cerebrospinal-fluid&#x201D; (<italic>n</italic> =&#x202F;215) and &#x201C;brain&#x201D; (<italic>n</italic> =&#x202F;213). These lexical clusters delineate primary research frontiers in glymphatic pathway investigations related to NDs. Lexical network mapping via VOSviewer (<xref ref-type="fig" rid="fig8">Figure 8A</xref>) employed two normalization criteria: frequency (&#x2265;15 occurrences) and semantic merging of equivalent terms, ultimately yielding a refined lexicon of 170 terms. Clustering of the network map based on keyword co-occurrence analysis was performed to reflect the basic knowledge structure of related research areas. CiteSpace software was used to cluster the keywords in the literature. This study utilized CiteSpace software and the log-likelihood ratio (LLR) method to cluster keywords from the literature, selecting g-index k&#x202F;=&#x202F;14 (the maximum value) to ensure high confidence and reduce noise. Under this strict threshold, 8 clusters were generated, while core themes remained clear (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). The clustering modularity (Q) value was 0.4457, and the mean silhouette (S) was 0.796, indicating significant clustering structure (Q&#x202F;&#x003E;&#x202F;0.3) and efficient, credible clustering (S&#x202F;&#x003E;&#x202F;0.7). To assess robustness, we examined changes in Q, S, and Harmonic Mean (Q, S) across different k values (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). As the k value decreased from 14 to 4, the number of clusters reduced, yet changes in Q and S stayed below 10%. Harmonic Mean (Q, S) remained stable, suggesting the overall clustering quality was consistent across various k values. Although the Harmonic Mean (Q, S) was below 0.6, the slight variations in Q and S demonstrate the robustness of the clustering results. The eight cluster labels are as follows: neurodegenerative diseases (#0), female (#1), Alzheimer&#x2019;s disease (#2), brain lymphatic system (#3), blood&#x2013;brain barrier (#4), lymphangiogenesis (#5), cognitive impairment (#6), and Virchow-Robin spaces (#7), detailed in <xref ref-type="table" rid="tab7">Table 7</xref>. The stability of core clustering themes further supports the robustness of the clustering results. When the frequency of a particular keyword increases sharply within a certain period, it is referred to as a burst keyword. This phenomenon provides important insights for identifying emerging research topics and hotspots in a given field (<xref ref-type="bibr" rid="ref26">Hou et al., 2023</xref>). <xref ref-type="fig" rid="fig8">Figure 8D</xref> displayed the top 25 keywords with the strongest citation bursts. The keyword with the highest citation burst was priority journal (15.6) from 2015 to 2020, followed by cerebral amyloid angiopathy (7.4) and interstitial fluid (6.96). The keywords with the longest duration of the strongest citation bursts were rat brain and central nervous system from 2012 to 2018. A timeline viewer for these keywords was constructed using CiteSpace. The timeline visualization categorizes keywords through temporal stratification, enabling chronological tracking of topic-specific developments across distinct research phases. <xref ref-type="fig" rid="fig8">Figure 8E</xref> illustrates the intellectual priorities and developmental pathways of glymphatic system studies in NDs.</p>
<table-wrap position="float" id="tab6">
<label>Table 6</label>
<caption>
<p>The top 20 keywords related to glymphatic system in NDs.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="center" valign="top">Keywords</th>
<th align="center" valign="top">Occurrences</th>
<th align="center" valign="top">Rank</th>
<th align="center" valign="top">Keywords</th>
<th align="center" valign="top">Occurrences</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">Glymphatic system</td>
<td align="center" valign="middle">695</td>
<td align="center" valign="middle">11</td>
<td align="center" valign="middle">Pathology</td>
<td align="center" valign="middle">100</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">Alzheimer&#x2019;s disease</td>
<td align="center" valign="middle">472</td>
<td align="center" valign="middle">12</td>
<td align="center" valign="middle">Interstitial fluid</td>
<td align="center" valign="middle">100</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">Human</td>
<td align="center" valign="middle">217</td>
<td align="center" valign="middle">13</td>
<td align="center" valign="middle">Impairment</td>
<td align="center" valign="middle">91</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="center" valign="middle">Cerebrospinal-fluid</td>
<td align="center" valign="middle">215</td>
<td align="center" valign="middle">14</td>
<td align="center" valign="middle">Mouse model</td>
<td align="center" valign="middle">87</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="center" valign="middle">Brain</td>
<td align="center" valign="middle">213</td>
<td align="center" valign="middle">15</td>
<td align="center" valign="middle">Magnetic resonance imaging</td>
<td align="center" valign="middle">83</td>
</tr>
<tr>
<td align="left" valign="middle">6</td>
<td align="center" valign="middle">Aquaporin 4</td>
<td align="center" valign="middle">161</td>
<td align="center" valign="middle">16</td>
<td align="center" valign="middle">Amyloid-beta</td>
<td align="center" valign="middle">82</td>
</tr>
<tr>
<td align="left" valign="middle">7</td>
<td align="center" valign="middle">Clearance</td>
<td align="center" valign="middle">128</td>
<td align="center" valign="middle">17</td>
<td align="center" valign="middle">Male</td>
<td align="center" valign="middle">80</td>
</tr>
<tr>
<td align="left" valign="middle">8</td>
<td align="center" valign="middle">Nonhuman</td>
<td align="center" valign="middle">114</td>
<td align="center" valign="middle">18</td>
<td align="center" valign="middle">Nuclear magnetic resonance imaging</td>
<td align="center" valign="middle">80</td>
</tr>
<tr>
<td align="left" valign="middle">9</td>
<td align="center" valign="middle">Sleep</td>
<td align="center" valign="middle">110</td>
<td align="center" valign="middle">19</td>
<td align="center" valign="middle">Metabolism</td>
<td align="center" valign="middle">78</td>
</tr>
<tr>
<td align="left" valign="middle">10</td>
<td align="center" valign="middle">Dementia</td>
<td align="center" valign="middle">107</td>
<td align="center" valign="middle">20</td>
<td align="center" valign="middle">Neurodegeneration</td>
<td align="center" valign="middle">71</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig8">
<label>Figure 8</label>
<caption>
<p><bold>(A)</bold> The Co-occurrence analysis of all key words by VOSviewer (a keyword with &#x2265;15 occurences, 170 keywords in total); <bold>(B)</bold> The cluster analysis of the keywords using CiteSpace; <bold>(C)</bold> Impact of varying g-index k on clustering quality indicators Q and S; <bold>(D)</bold> Top 25 keywords with the strongest ciatation bursts by CiteSpace; <bold>(E)</bold> CiteSpace visualization map of timeline viewer related to glymphatic system in NDs.</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g008.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">A network visualization map displays interconnected keywords related to the glymphatic system, Alzheimer's disease, and cerebrospinal fluid, with clusters in red, yellow, and blue. A second map shows thematic clusters labeled with topics like degenerative disease and cognitive impairment, using different colors to indicate each area. Line graph and bar chart. The line graph shows index values for Modularity, Mean Silhouette, and Harmonic Mean across g-index k values. The bar chart lists the top 25 keywords with citation bursts from 2012 to 2024, highlighting significant keywords like "rat brain," "central nervous system," and "priority journal," with citation strengths and durations represented by colored bars. Visualization of research clusters from 2012 to 2024 based on citations and topics. Key areas include degenerative diseases, Alzheimer's disease, and the glymphatic system. Colors represent different themes, with nodes sized by significance. Prominent years are marked along the top.</alt-text>
</graphic>
</fig>
<table-wrap position="float" id="tab7">
<label>Table 7</label>
<caption>
<p>Cluster analysis results of glymphatic system research in NDs.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">ClusterID</th>
<th align="center" valign="top">Silhouette</th>
<th align="center" valign="top">mean (Year)</th>
<th align="left" valign="top">Label (LSI)</th>
<th align="left" valign="top">Label (LLR)</th>
<th align="left" valign="top">Label (MI)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">0</td>
<td align="center" valign="middle">0.618</td>
<td align="center" valign="middle">2019</td>
<td align="left" valign="middle">Glymphatic system; central nervous system disease; mood disorder; perivascular space; transcription factor | s disease; endothelial cells; substantia nigra; gut microbiota; reactive oxygen speciess</td>
<td align="left" valign="middle">Degenerative disease (16.66, 1.0E-4); female (13.78, 0.001); microglia (13.77, 0.001); male (13.08, 0.001); stem cell niche (11.02, 0.001)</td>
<td align="left" valign="middle">Bacterial infection (0.94); 3 d cultures (0.94); c</td>
</tr>
<tr>
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">0.83</td>
<td align="center" valign="middle">2020</td>
<td align="left" valign="middle">Magnetic resonance; systolic blood; apparent diffusion; diastolic blood; community dwelling | glymphatic system; magnetic resonance imaging; perivascular spaces; robin spaces; paravascular spaces</td>
<td align="left" valign="middle">Female (37.71, 1.0E-4); male (32.65, 1.0E-4); aged (29.73, 1.0E-4); middle aged (27.66, 1.0E-4); longitudinal study (17.78, 1.0E-4)</td>
<td align="left" valign="middle">18f-florzolotau (1.01); clearance syste</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">0.874</td>
<td align="center" valign="middle">2015</td>
<td align="left" valign="middle">Glymphatic system; perivascular spaces; choroid plexus; dural lymphatics; glymphatic pathways | alzheimers disease; 4d flow mri; mean blood flow; pulsatility index; brain tumorigenesis</td>
<td align="left" valign="middle">Alzheimers disease (70.79, 1.0E-4); interstitial fluid (27.52, 1.0E-4); clearance (25.86, 1.0E-4); aqp4 (23.42, 1.0E-4); mouse model (23.19, 1.0E-4)</td>
<td align="left" valign="middle">Autoimmunity (1.17); chronic pain (1.17); coffee p</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">0.843</td>
<td align="center" valign="middle">2017</td>
<td align="left" valign="middle">Cerebrospinal fluid; glymphatic pathway; perivascular space; animal models; glucocorticoid receptor | amyloid beta; blood brain; nuclear magnetic resonance; endothelial nitric oxide; beta adrenergic receptor</td>
<td align="left" valign="middle">Alzheimers disease (12.17, 0.001); glymphatic system (10.5, 0.005); animal model (8.92, 0.005); mouse (8.92, 0.005); mice (8.92, 0.005)</td>
<td align="left" valign="middle">Cell transport (0.7); cerebellum (0.7); chemistry</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="center" valign="middle">0.828</td>
<td align="center" valign="middle">2016</td>
<td align="left" valign="middle">Glymphatic system; cerebrospinal fluid; waste clearance; transgenic mouse; sleep disorders | alzheimers disease; blood&#x2013;brain barrier; reactive astrocytes; hyaluronic acid; plga nanoparticles</td>
<td align="left" valign="middle">Glymphatic system (25.93, 1.0E-4); blood&#x2013;brain barrier (18.92, 1.0E-4); sleep (15.71, 1.0E-4); sleep deprivation (15.53, 1.0E-4); glymphatic (11.8, 0.001)</td>
<td align="left" valign="middle">cerebrovascular activity (0.98); brain ventricles</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="center" valign="middle">0.781</td>
<td align="center" valign="middle">2020</td>
<td align="left" valign="middle">Glymphatic system; perivascular spaces; paravascular spaces; magnetic resonance imaging; brain cysts | cerebrospinal fluid; blood brain; chronic kidney; renal replacement; nervous system</td>
<td align="left" valign="middle">Alzheimers disease (12.71, 0.001); lymphangiogenesis (9.37, 0.005); glioma (9.37, 0.005); subarachnoid hemorrhage (9.37, 0.005); lymphatic drainage (8.46, 0.005)</td>
<td align="left" valign="middle">Neuroinvasive pathways (0.52); hydrocephalus (0.52)</td>
</tr>
<tr>
<td align="left" valign="middle">6</td>
<td align="center" valign="middle">0.957</td>
<td align="center" valign="middle">2019</td>
<td align="left" valign="middle">Glymphatic system; parkinsons disease; lewy bodies dementia; multisystem atrophy; circadian blood pressure patterns | s disease; sleep disorders; tau proteins; melatonin levels; cholinesterase inhibitors</td>
<td align="left" valign="middle">cognitive impairment (23.16, 1.0E-4); diagnosis (11.92, 0.001); alzheimer disease (11.66, 0.001); alzheimer&#x2019;s disease (11.2, 0.001); dementia (8.69, 0.005)</td>
<td align="left" valign="middle">cadherins (0.24); transgenic mice (0.24); neurosci</td>
</tr>
<tr>
<td align="left" valign="middle">7</td>
<td align="center" valign="middle">0.983</td>
<td align="center" valign="middle">2019</td>
<td align="left" valign="middle">Glymphatic system; cerebral small vessel disease; enlarged perivascular spaces; impaired cognition; capillary rarefaction | perivascular space; multiple sclerosis; csf shunting; csf dynamic disturbances; glymphatic circulation</td>
<td align="left" valign="middle">Virchow robin spaces (22.41, 1.0E-4); small vessel disease (15.83, 1.0E-4); blood brain barrier (bbb) (14.93, 0.001); perivascular space (pvs) (14.93, 0.001); cerebral small vessel disease (10.27, 0.005)</td>
<td align="left" valign="middle">Spectral analysis (0.1); Glucocerebrosidase (0.1)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec17">
<label>3.8</label>
<title>Tripartite network analysis of author-keyword-journal interconnections</title>
<p>The tripartite network visualization methodology facilitates systematic integration and examination of multidimensional relationships between bibliometric entities through the construction of interconnected node-edge mappings. Applying this three-dimensional network analysis framework to bibliometric data, we established three interconnected domains: &#x201C;Author&#x201D; (left panel), &#x201C;keyword&#x201D; (central panel), and &#x201C;journal&#x201D; (right panel), generating an integrated &#x201C;author-keyword-journal&#x201D; knowledge architecture as visualized in <xref ref-type="fig" rid="fig9">Figure 9</xref>. The analysis reveals that the research hotspots are primarily concentrated in two core areas: the &#x201C;Glymphatic system&#x201D; and &#x201C;Neurodegenerative diseases&#x201D; (with a particular focus on &#x201C;Alzheimer&#x2019;s disease&#x201D; and &#x201C;Parkinson&#x2019;s disease&#x201D;). This highlights the significance and intrinsic connection between these two research directions. Additionally, high-frequency keywords also involve cutting-edge topics such as &#x201C;cerebrospinal fluid,&#x201D; &#x201C;aquaporin-4,&#x201D; &#x201C;<italic>&#x03B2;</italic>-amyloid,&#x201D; and &#x201C;sleep.&#x201D; In the co-occurrence network analysis of authors and keywords, the research of Professors Nedergaard M. and Xiao M. is significantly associated with both the &#x201C;glymphatic system&#x201D; and &#x201C;Alzheimer&#x2019;s disease.&#x201D; In contrast, Professor Iliff J. J. has focused his research on the relationship between &#x201C;Aquaporin-4&#x201D; and the Glymphatic system. The journal-keyword analysis indicates that studies on the &#x201C;glymphatic system&#x201D; are mainly published in three authoritative journals: <italic>International Journal of Molecular Sciences, Journal of Cerebral Blood Flow and Metabolism, and Frontiers in Aging Neuroscience</italic>. Research on &#x201C;Alzheimer&#x2019;s disease&#x201D; exhibits a bimodal distribution in <italic>International Journal of Molecular Sciences</italic> and <italic>Journal of Alzheimer&#x2019;s Disease.</italic> Studies related to &#x201C;cerebrospinal fluid&#x201D; are predominantly featured in <italic>Journal of Cerebral Blood Flow and Metabolism</italic>. Through this network topology analysis, not only have the influential core scholars in the field and their research directions been clearly identified, but also the important status of <italic>International Journal of Molecular Sciences</italic>, <italic>Journal of Alzheimer&#x2019;s Disease</italic>, and <italic>Frontiers in Aging Neuroscience</italic> as key academic dissemination platforms driving the development of this discipline has been established.</p>
<fig position="float" id="fig9">
<label>Figure 9</label>
<caption>
<p>Tripartite network visualization of author-keyword-journal relationships.</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g009.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Sankey diagram visualizing the connections between authors (AU), disease/conditions (DE), and scientific journals (SO). Authors on the left, such as Xiao M and Nedergaard M, are linked to topics like the glymphatic system and Alzheimer's disease. These topics connect to journals like the International Journal of Molecular Sciences and Neuroimage. The diagram uses colored bars and flowing lines to illustrate relationships and contributions visually.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec18">
<label>3.9</label>
<title>Co-cited references and reference bursts analysis</title>
<p>CiteSpace was utilized to identify the top ten most frequently cited references related to the glymphatic system in NDs (<xref ref-type="table" rid="tab8">Table 8</xref>). Each of these ten references has received 65 or more citations. Notably, the article ranked first is &#x201C;Glymphatic failure as a final common pathway to dementia&#x201D; by <xref ref-type="bibr" rid="ref40">Nedergaard and Goldman (2020)</xref> cited 106 times; the second is &#x201C;Impaired glymphatic function and clearance of tau in an Alzheimer&#x2019;s disease model&#x201D; by <xref ref-type="bibr" rid="ref23">Harrison et al. (2020)</xref> cited 95 times; and the third is &#x201C;The glymphatic pathway in neurological disorders&#x201D; by Rasmussen MK et al., cited 93 times. From the citation counts of the top three articles, it is evident that the pathways and functions of the glymphatic system play a crucial role in the onset and progression of NDs. The analysis of citation bursts among references is a powerful tool for pinpointing documents that have garnered a sudden increase in citations over a particular timeframe. This not only highlights research hotspots but also delineates prevailing trends. It serves as a crucial guide for uncovering nascent themes and key research concentrations within a given domain. In this study, a total of 25 references with the most pronounced citation bursts were detected, as depicted in <xref ref-type="fig" rid="fig10">Figure 10</xref>. The top three most cited references are titled &#x201C;Sleep Drives Metabolite Clearance from the Adult Brain&#x201D; (Burst Strength: 27.5; published in 2013), &#x201C;Impairment of paravascular clearance pathways in the Aging Brain&#x201D; (Burst Strength: 24.1; published in 2014), and &#x201C;Structural and functional features of central nervous system lymphatic vessels&#x201D; (Burst Strength: 23.25; published in 2015). <xref ref-type="fig" rid="fig10">Figure 10</xref> displays that there are 12 articles with a citation period of more than 4&#x202F;years, indicating that these articles have garnered more sustained attention. One article is currently still in the period of citation burst, which can reflect, to some extent, the developmental direction of glymphatic system research in NDs at present and in the future.</p>
<table-wrap position="float" id="tab8">
<label>Table 8</label>
<caption>
<p>The top 10 co-cited references related to glymphatic system in NDs.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="top">Rank</th>
<th align="center" valign="top">Year</th>
<th align="center" valign="top">Author</th>
<th align="left" valign="top">Title</th>
<th align="center" valign="top">Journal</th>
<th align="center" valign="top">Citation</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">1</td>
<td align="center" valign="middle">2020</td>
<td align="center" valign="middle">Nedergaard M.</td>
<td align="left" valign="middle">Glymphatic failure as a final common pathway to dementia</td>
<td align="center" valign="middle">Science</td>
<td align="center" valign="middle">106</td>
</tr>
<tr>
<td align="left" valign="middle">2</td>
<td align="center" valign="middle">2020</td>
<td align="center" valign="middle">Harrison Ian F.</td>
<td align="left" valign="middle">Impaired glymphatic function and clearance of tau in an Alzheimer&#x2019;s disease model</td>
<td align="center" valign="middle">Brain</td>
<td align="center" valign="middle">95</td>
</tr>
<tr>
<td align="left" valign="middle">3</td>
<td align="center" valign="middle">2018</td>
<td align="center" valign="middle">Rasmussen M. K.</td>
<td align="left" valign="middle">The glymphatic pathway in neurological disorders</td>
<td align="center" valign="middle">Lancet Neurol</td>
<td align="center" valign="middle">93</td>
</tr>
<tr>
<td align="left" valign="middle">4</td>
<td align="center" valign="middle">2018</td>
<td align="center" valign="middle">Mestre H.</td>
<td align="left" valign="middle">Aquaporin-4-dependent glymphatic solute transport in the rodent brain</td>
<td align="center" valign="middle">Elife</td>
<td align="center" valign="middle">87</td>
</tr>
<tr>
<td align="left" valign="middle">5</td>
<td align="center" valign="middle">2019</td>
<td align="center" valign="middle">Zou W. Y.</td>
<td align="left" valign="middle">Blocking meningeal lymphatic drainage aggravates Parkinson&#x2019;s disease-like pathology in mice overexpressing mutated &#x03B1;-synuclein</td>
<td align="center" valign="middle">Transl Neurodegener</td>
<td align="center" valign="middle">76</td>
</tr>
<tr>
<td align="left" valign="middle">6</td>
<td align="center" valign="middle">2018</td>
<td align="center" valign="middle">Da Mesquita S.</td>
<td align="left" valign="middle">Functional aspects of meningeal lymphatics in ageing and Alzheimer&#x2019;s disease</td>
<td align="center" valign="middle">Nature</td>
<td align="center" valign="middle">75</td>
</tr>
<tr>
<td align="left" valign="middle">7</td>
<td align="center" valign="middle">2020</td>
<td align="center" valign="middle">Hablitz L. M.</td>
<td align="left" valign="middle">Circadian control of brain glymphatic and lymphatic fluid flow</td>
<td align="center" valign="middle">Nat commun</td>
<td align="center" valign="middle">71</td>
</tr>
<tr>
<td align="left" valign="middle">8</td>
<td align="center" valign="middle">2017</td>
<td align="center" valign="middle">Zeppenfeld D. M.</td>
<td align="left" valign="middle">Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains</td>
<td align="center" valign="middle">JAMA Neurol</td>
<td align="center" valign="middle">67</td>
</tr>
<tr>
<td align="left" valign="middle">9</td>
<td align="center" valign="middle">2018</td>
<td align="center" valign="middle">Mestre H.</td>
<td align="left" valign="middle">Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in hypertension</td>
<td align="center" valign="middle">Nat commun</td>
<td align="center" valign="middle">65</td>
</tr>
<tr>
<td align="left" valign="middle">10</td>
<td align="center" valign="middle">2019</td>
<td align="center" valign="middle">Hablitz L. M.</td>
<td align="left" valign="middle">Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia</td>
<td align="center" valign="middle">Sci Adv</td>
<td align="center" valign="middle">65</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig position="float" id="fig10">
<label>Figure 10</label>
<caption>
<p>Citations burst dynamics: top 25 references analysis.</p>
</caption>
<graphic xlink:href="fnagi-17-1598608-g010.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Top 25 references with the strongest citation bursts are displayed in a table. Each entry includes author names, publication details, DOI links, citation burst strength, and a color-coded timeline from 2012 to 2024, indicating burst periods.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec19">
<label>4</label>
<title>Discussion</title>
<sec id="sec20">
<label>4.1</label>
<title>Global research trends</title>
<p>This study employs scientometric visualization tools to map temporal dynamics and intellectual focal points in glymphatic system research associated with NDs across the 2012&#x2013;2024 period. Our findings reveal that during the initial period from 2012 to 2016, the publication volume remained relatively limited, yet this stage established essential groundwork for deciphering the glymphatic system&#x2019;s role in NDs. The early developmental phase spanning 2017 to 2019 saw gradual growth in scholarly output, while the rapid expansion phase from 2020 to 2023 experienced a substantial rise in literature, signaling heightened academic interest. By 2024, annual publications surged to 233, representing a 1.47-fold increase compared to 2023, a trajectory suggesting sustained growth and cementing the glymphatic system as a pivotal focus for future NDs investigations. In terms of publication type structure, original articles dominate among the high-quality literature collected (accounting for approximately 61.39%), while review articles account for 38.61%. This structural feature indicates that the field is primarily driven by empirical and mechanistic investigations. However, as research continues to deepen, the number of review articles has gradually increased, providing a theoretical foundation and directional guidance for knowledge integration, frontier advancement, and paradigm shifts within the field. Overall, research on the glymphatic system and NDs has evolved from the initial stage of theoretical emergence and basic exploration to a period characterized by mechanistic refinement and comprehensive synthesis. In the future, with the continued accumulation of original research achievements and the ongoing emergence of high-impact review articles, this field is expected to accelerate toward a new stage marked by interdisciplinary integration, translational application, and theoretical leadership.</p>
<p>Research priorities center on foundational mechanisms, clinical translation, and imaging evaluation, with neuroscience accounting for the largest thematic share. Temporally, publication trends exhibit both chronological evolution and geographic-institutional stratification. From a temporal perspective, the publication trends not only reflect chronological evolution but also reveal distinct patterns of geographic and institutional stratification. Globally, research output is predominantly concentrated in four major regions: Asia, Europe, North America, and Australia. Among these, China and the United States lead in both publication volume and citation impact, followed by Italy and Japan. In terms of institutional contributions, Chinese universities account for the highest overall output (109 articles, 30.70%), with institutions from the United States and Denmark also ranking among the top performers. Notably, the University of Rochester in the United States stands out globally for both the number of publications and citation influence, further consolidating the country&#x2019;s leading position in this field. Leading universities from Denmark and Japan have also demonstrated exceptional academic performance. Chinese universities maintain close collaborations with research institutions in other countries, underscoring China&#x2019;s rapid progress and growing influence in the international academic community. However, some institutions, such as Massachusetts General Hospital and Eindhoven University of Technology in the Netherlands, have not yet established close cooperative relationships with core research institutions in China, the United States, and other major countries. Therefore, strengthening academic exchange and international collaboration is essential for advancing research on the glymphatic system and NDs worldwide. <xref ref-type="table" rid="tab3">Table 3</xref> presents the top 10 core journals related to glymphatic system and NDs research. Most of these journals are classified as JCR Q1, highlighting the strong academic impact and global standing of research in this area. Similarly, the majority of the top 10 most-cited journals also belong to JCR Q1, including well-regarded journals such as <italic>Brain</italic>, <italic>Journal of Cerebral Blood Flow and Metabolism</italic>, and <italic>Neurobiology of Disease</italic>. This not only demonstrates the high recognition that glymphatic system research has earned from the academic community, but also further confirms the significance of these journals within the field. Many high-quality, high-impact journals have shown a strong interest in this area, providing strong support for the dissemination and development of related research. Overall, our research findings will help researchers quickly and accurately identify suitable journals to obtain the latest advancements or publish articles in the field of the glymphatic system and NDs. Combined with the summary of the glymphatic system and NDs research field in <xref ref-type="fig" rid="fig3">Figure 3</xref> and the dual map overlay of journals in <xref ref-type="fig" rid="fig6">Figure 6C</xref>, it is evident that the system is currently shifting towards clinical translation and updates in imaging techniques. In addition, a systematic analysis of core authors and their co-citation networks in the global research field of the glymphatic system and NDs reveals that Chinese authors rank first worldwide in both the number of publications and total citations. However, their academic output is dominated by original articles, with a relatively low proportion of review papers, and the citation per paper is significantly lower than that of top teams from developed countries such as Denmark. For instance, although the total number of publications from the Nedergaard M. is less than that of the group of Chinese authors, their output features a more balanced structure and a higher proportion of review papers, resulting in an impressive average citation count of 266.56 per paper, which highlights a &#x201C;quality-first and balanced development&#x201D; research strategy. Further analysis of the collaboration network shows that, although Chinese authors demonstrate strong cohesion regionally, in-depth collaboration with leading international teams&#x2014;particularly those represented by Iliff from the United States&#x2014;remains insufficient. Therefore, it is recommended that Chinese authors, while continuing to strengthen their capacity for original research, further optimize their academic output structure, enhance the innovativeness and international impact of their research, and actively pursue high-level international collaborations. Such efforts will facilitate a shift from &#x201C;quantity-driven&#x201D; to &#x201C;quality-led&#x201D; development in the field. This strategic adjustment is of great significance for promoting theoretical innovation and achieving major breakthroughs in global research on the glymphatic system in NDs. Nevertheless, continuously improving the scientific rigor of research methods and deepening theoretical insight remain key to future academic advancement. At the same time, establishing cross-institutional collaborative networks and fostering synergistic innovation will be important strategies for driving paradigm shifts and realizing significant research progress.</p>
</sec>
<sec id="sec21">
<label>4.2</label>
<title>Knowledge base</title>
<p>Co-citation analysis constitutes a rigorous methodological framework for quantifying conceptual linkages between scholarly publications. Frequent citation patterns typically denote seminal conceptual frameworks within a research domain, while primary investigations serve as critical vectors for disciplinary innovation. Our scientometric evaluation of 865 peer-reviewed studies addressing glymphatic-neurodegenerative interactions employed citation frequency thresholds to identify ten paradigm-defining works. The review &#x201C;Glymphatic failure as a final common pathway to dementia&#x201D; by <xref ref-type="bibr" rid="ref40">Nedergaard and Goldman (2020)</xref> published in <italic>Science</italic> in 2020 (cited 106 times), is the most frequently cited paper in this field. The authors propose that dysfunction of the glymphatic system may be a common pathological mechanism underlying various dementias, including Alzheimer&#x2019;s disease and vascular dementia. The article summarizes both basic and clinical research, noting that with age, the glymphatic system&#x2019;s ability to clear brain metabolic waste declines, leading to the accumulation of harmful proteins such as A&#x03B2; and tau, which results in neuronal damage and cognitive decline. Sleep disturbances, cardiovascular risks like hypertension, and trauma can accelerate this process. Early improvement of glymphatic function is considered important for dementia prevention. The second highly cited article is &#x201C;Impaired glymphatic function and clearance of tau in an Alzheimer&#x2019;s disease model&#x201D; by <xref ref-type="bibr" rid="ref23">Harrison et al. (2020)</xref> published in <italic>Brain</italic> in 2020. This study, using a P301S mutant tau mouse model, found that the glymphatic system&#x2019;s clearance of tau was reduced by 40% compared to normal mice, closely associated with the loss of astrocytic AQP4 polarity. This leads to abnormal tau accumulation and neuronal loss, directly confirming the key link between the glymphatic system and tau pathology. The third article, published by <xref ref-type="bibr" rid="ref43">Rasmussen et al. (2018)</xref> in <italic>The Lancet Neurology</italic> in 2018, systematically reviews the role of the glymphatic system in Alzheimer&#x2019;s disease, traumatic brain injury (TBI), stroke, and migraine. Glymphatic dysfunction is a common feature in these disorders; for example, reduced clearance in traumatic brain injury (TBI) leads to brain edema and accumulation of inflammatory products, while stagnant glymphatic flow during stroke worsens neuronal damage, highlighting its broad pathological significance. The fourth article, &#x201C;Aquaporin-4-dependent glymphatic solute transport in the rodent brain&#x201D; by <xref ref-type="bibr" rid="ref36">Mestre et al. (2018)</xref>, compared AQP4 knockout mice with wild-type mice and showed that AQP4 deficiency significantly reduces glymphatic flow speed and clearance efficiency, and increases A&#x03B2; deposition, underscoring the central role of AQP4 in glymphatic transport. The fifth article by <xref ref-type="bibr" rid="ref67">Zou et al. (2019)</xref> published in <italic>Translational Neurodegeneration</italic> in 2019, showed that blocking meningeal lymphatic drainage in a Parkinson&#x2019;s disease mouse model led to increased aggregation of <italic>&#x03B1;</italic>-synuclein, greater loss of dopaminergic neurons in the substantia nigra, and worsened motor deficits, along with increased infiltration of peripheral immune cells into the brain. This suggests that the meningeal lymphatic system is involved in both the clearance of harmful proteins and the regulation of inflammation, playing an important role in Parkinson&#x2019;s disease progression. The sixth article by <xref ref-type="bibr" rid="ref15">Da Mesquita et al. (2018)</xref>, published in <italic>Nature</italic> in 2018, found that aging and AD model mice exhibit degeneration and dysfunction of meningeal lymphatic vessels and reduced A&#x03B2; clearance in the brain. Promoting lymphangiogenesis improved these indicators, indicating that degeneration of meningeal lymphatics is a key factor in AD-related protein accumulation. The seventh article by <xref ref-type="bibr" rid="ref21">Hablitz et al. (2020)</xref> published in <italic>Nature Communications</italic> in 2020, was the first to show that glymphatic and meningeal lymphatic flow rates in mice have a clear day-night rhythm, being higher at night than during the day. Disruption of circadian rhythms lowers A&#x03B2; clearance, suggesting that sleep and circadian rhythms are important for glymphatic function and brain health. The eighth article by <xref ref-type="bibr" rid="ref61">Zeppenfeld et al. (2017)</xref> published in <italic>JAMA Neurology</italic> in 2017, analyzed postmortem brain tissue and found the loss of perivascular AQP4 polarity was much greater in AD patients than in controls and was associated with the Apolipoprotein E epsilon 4 allele (APOE &#x03B5;4) genotype, indicating that AQP4 localization is closely related to glymphatic function and cognitive impairment in AD. The ninth article by <xref ref-type="bibr" rid="ref36">Mestre et al. (2018)</xref> published in <italic>Nature Communications</italic> in 2018, showed that hypertension reduces arterial pulsatility and cerebrospinal fluid flow, decreases A&#x03B2; clearance, and impairs spatial memory, while antihypertensive treatment can partially reverse these effects. This highlights the importance of blood pressure control in preventing cognitive impairment. The tenth article by <xref ref-type="bibr" rid="ref22">Hablitz et al. (2019)</xref> published in <italic>Science Advances</italic> in 2019, demonstrated that under anesthesia, increased electroencephalogram delta waves and low heart rate enhance glymphatic flow in mice, which is associated with expansion of the interstitial space. This state mimics glymphatic activation during deep sleep and provides a theoretical basis for non-invasively modulating glymphatic function.</p>
<p>Overall, the ten most highly co-cited references based on annual average citations have not only laid a solid theoretical foundation for understanding the mechanistic link between NDs and the glymphatic system, but have also accelerated the translation of basic research into clinical applications. Published in JCR Q1 journals within the field, these high-impact articles&#x2014;including comprehensive systematic reviews and pioneering empirical studies&#x2014;primarily focus on the fundamental mechanisms of the glymphatic system in NDs, key discoveries using animal models, and early clinical evidence. Collectively, these works have played a leading role in elucidating the relationship between NDs and the glymphatic system.</p>
</sec>
<sec id="sec22">
<label>4.3</label>
<title>Research hot spots and frontiers</title>
<p>Keyword analysis as an important tool for evaluating research hotspots and the evolution of scientific disciplines has revealed the current cutting-edge topics in the field of NDs for this study. A systematic review of high-frequency keywords such as &#x201C;glymphatic system&#x201D; &#x201C;Alzheimer&#x2019;s disease&#x201D; &#x201C;cerebrospinal fluid&#x201D; &#x201C;Aquaporin 4&#x201D; &#x201C;clearance&#x201D; &#x201C;sleep&#x201D; and &#x201C;pathology&#x201D; demonstrates that current academic attention is primarily focused on the role of the glymphatic system in regulating cerebrospinal fluid dynamics metabolic waste clearance AQP4-related mechanisms and regulatory factors such as sleep&#x2014;especially with regard to the specific mechanisms in major diseases like AD. Further keyword clustering analysis (<xref ref-type="fig" rid="fig8">Figure 8B</xref>; <xref ref-type="fig" rid="fig7">Table 7</xref>) more intuitively delineates the research directions and main connotations in this field. Specifically the eight clusters cover NDs as a whole (Cluster 0) sex-related factors (Cluster 1) Alzheimer&#x2019;s disease (Cluster 2) glymphatic system mechanisms (Cluster 3) blood&#x2013;brain barrier (Cluster 4) lymphangiogenesis (Cluster 5) cognitive impairment (Cluster 6) and specific cerebral structures such as Virchow-Robin spaces (Cluster 7). These clusters encompass research subjects regulatory factors mechanisms of action and also include specific anatomical structures and physiological pathways. Based on the above analysis future research should further focus on the following specific directions:</p>
<sec id="sec23">
<label>4.3.1</label>
<title>Mechanistic insights into the glymphatic system&#x2019;s role in NDs pathology</title>
<p>The glymphatic system is now recognized as the primary pathway for clearing metabolic waste and neurotoxic proteins&#x2014;such as A&#x03B2; and tau&#x2014;from the brain, and significant clinical and preclinical evidence has linked its dysfunction to the onset and progression of NDs, including AD and PD (<xref ref-type="bibr" rid="ref44">Rehman et al., 2024</xref>; <xref ref-type="bibr" rid="ref8">Beschorner and Nedergaard, 2024</xref>). Advances such as functional MRI have enabled noninvasive assessment of glymphatic activity, revealing that both cerebrospinal fluid clearance and glymphatic flow decline with age, which correlates with increased brain aging and vulnerability to disease (<xref ref-type="bibr" rid="ref34">Malis et al., 2024</xref>; <xref ref-type="bibr" rid="ref39">Naganawa et al., 2024</xref>). Nonetheless, critical questions remain&#x2014;particularly regarding the molecular underpinnings, dynamic regulation, and cooperative interactions between the glymphatic system, meningeal lymphatics, and other clearance pathways. Some researchers also emphasize anatomical and functional heterogeneity between human and animal models, which further complicates mechanistic conclusions (<xref ref-type="bibr" rid="ref29">Jessen et al., 2015</xref>; <xref ref-type="bibr" rid="ref38">Mestre et al., 2020</xref>). Extensive animal and translational studies demonstrate that impaired glymphatic function not only blocks the efflux of A&#x03B2;, tau, and other toxic proteins&#x2014;leading to their aberrant accumulation&#x2014;but also exacerbates neuroinflammation and neuronal loss, thus advancing cognitive decline and acting as a final common pathway for diseases such as AD and PD (<xref ref-type="bibr" rid="ref10">Boland et al., 2018</xref>; <xref ref-type="bibr" rid="ref43">Rasmussen et al., 2018</xref>; <xref ref-type="bibr" rid="ref40">Nedergaard and Goldman, 2020</xref>; <xref ref-type="bibr" rid="ref16">Ding et al., 2021</xref>; <xref ref-type="bibr" rid="ref28">Ishida et al., 2022</xref>). Importantly, modifiable factors like exercise, especially high-intensity interval training, have been shown to enhance astrocytic AQP4 polarization and boost glymphatic clearance, whereas sleep disturbances substantially impair glymphatic activity and independently increase neurodegenerative risk (<xref ref-type="bibr" rid="ref17">Feng et al., 2023</xref>; <xref ref-type="bibr" rid="ref19">Gottesman et al., 2024</xref>). Despite growing recognition of the glymphatic system&#x2019;s crucial involvement in the etiology and progression of NDs, key obstacles remain, including suboptimal imaging sensitivity, standardization issues, discrepancies between animal and human studies, limited mechanistic depth, and the uncertain clinical efficacy of targeted interventions. Moving forward, the field stands to benefit from large-scale human studies, innovative dynamic molecular imaging, and multicenter interventional trials to further advance foundational understanding and enable effective clinical translation.</p>
</sec>
<sec id="sec24">
<label>4.3.2</label>
<title>The core role of AQP4 and its polarization in cerebrospinal fluid flow and clearance function</title>
<p>AQP4 is highly polarized and distributed at the perivascular end-feet of astrocytes, serving as the molecular basis for the exchange between cerebrospinal fluid (CSF) and interstitial fluid (ISF), and for the efficient transport of waste via the glymphatic system (<xref ref-type="bibr" rid="ref27">Iliff et al., 2012</xref>). A substantial body of research has demonstrated that the polarized state of AQP4 determines the efficiency with which CSF can drive the clearance of macromolecules such as A&#x03B2;, tau, and <italic>&#x03B1;</italic>-synuclein (<xref ref-type="bibr" rid="ref36">Mestre et al., 2018</xref>; <xref ref-type="bibr" rid="ref28">Ishida et al., 2022</xref>; <xref ref-type="bibr" rid="ref18">Gomolka et al., 2023</xref>; <xref ref-type="bibr" rid="ref62">Zhang et al., 2023</xref>). Genetic models have shown that both AQP4 knockout and loss of its polarization (e.g., Snta1 mutation) lead to impaired CSF-ISF exchange and waste accumulation, ultimately resulting in A&#x03B2; plaque formation, tau deposition, and exacerbation of cognitive dysfunction (<xref ref-type="bibr" rid="ref61">Zeppenfeld et al., 2017</xref>; <xref ref-type="bibr" rid="ref48">Simon et al., 2022</xref>; <xref ref-type="bibr" rid="ref18">Gomolka et al., 2023</xref>). In human aging and in AD patients, loss of AQP4 polarization is highly correlated with cognitive decline, highlighting this molecular marker as a novel target for diagnosis and intervention (<xref ref-type="bibr" rid="ref61">Zeppenfeld et al., 2017</xref>). In models of neurological diseases such as PD, impaired AQP4 repolarization further aggravates &#x03B1;-synuclein aggregation and inflammatory responses, suggesting its broad neuroprotective significance (<xref ref-type="bibr" rid="ref62">Zhang et al., 2023</xref>; <xref ref-type="bibr" rid="ref47">Si et al., 2024</xref>). The polarization of AQP4 is regulated by multiple factors, including protein complexes and matrix metalloproteinase Matrix metalloproteinase-9; targeted modulation of these pathways has been shown to partially restore glymphatic function and reverse pathological progression (<xref ref-type="bibr" rid="ref47">Si et al., 2024</xref>). Physiological interventions such as high-intensity training and circadian rhythm synchronization can also effectively enhance AQP4 polarization and promote brain waste clearance (<xref ref-type="bibr" rid="ref21">Hablitz et al., 2020</xref>; <xref ref-type="bibr" rid="ref17">Feng et al., 2023</xref>). However, it is important to note that the upstream regulatory networks of AQP4 polarization remain unclear, noninvasive and dynamic clinical monitoring tools are lacking, and interdisciplinary approaches such as AI imaging and biomarker analysis have yet to be widely applied&#x2014;leaving translational pathways in need of further integration (<xref ref-type="bibr" rid="ref37">Mestre et al., 2017</xref>; <xref ref-type="bibr" rid="ref1">Abbott et al., 2018</xref>; <xref ref-type="bibr" rid="ref43">Rasmussen et al., 2018</xref>; <xref ref-type="bibr" rid="ref7">Benveniste et al., 2019</xref>). Future directions should focus on elucidating the dynamic regulatory mechanisms of AQP4 polarization, developing imaging and molecular monitoring systems, and achieving precision interventions and innovations in diagnosis and therapy targeting this new molecule.</p>
</sec>
<sec id="sec25">
<label>4.3.3</label>
<title>Dialectical impact of the interaction between multidimensional regulatory factors and the coupling mechanism of the brain waste clearance system on the progression of neurological diseases</title>
<p>The brain waste clearance system comprises a complex, multilayered network that includes the glymphatic system, meningeal lymphatic vessels, the blood&#x2013;brain barrier, and brain microstructures, and its function is regulated by the coordinated action of multiple endogenous and exogenous factors (<xref ref-type="bibr" rid="ref59">Yankova et al., 2021</xref>). High-quality deep sleep significantly enhances the metabolic waste clearance efficiency of the glymphatic system and CSF flow; during sleep, the interstitial space between brain cells expands substantially (by approximately 60%), facilitating faster CSF circulation and more efficient clearance of solute waste products such as A&#x03B2; (with clearance efficiency approximately 2 times higher than during wakefulness) (<xref ref-type="bibr" rid="ref56">Xie et al., 2013</xref>). Conversely, sleep disturbances not only damage the glymphatic network but also directly undermine the blood&#x2013;brain barrier, leading to inflammatory activation and abnormal protein accumulation, thus serving as risk factors for NDs (<xref ref-type="bibr" rid="ref4">Avilez-Avilez et al., 2024</xref>; <xref ref-type="bibr" rid="ref19">Gottesman et al., 2024</xref>; <xref ref-type="bibr" rid="ref41">Ozdinler, 2024</xref>). Similarly, aging induces an overall decline in CSF outflow and glymphatic efficiency, accompanied by expansion of perivascular spaces, microenvironmental dysregulation, and glial activation, which further impede waste clearance and provide both anatomical and molecular bases for cognitive dysfunction (<xref ref-type="bibr" rid="ref3">Andriuta et al., 2024</xref>; <xref ref-type="bibr" rid="ref34">Malis et al., 2024</xref>; <xref ref-type="bibr" rid="ref57">Xiong et al., 2024</xref>). Sex differences are also reflected in the expression of relevant genes, channel functions, and disease susceptibility, but mechanistic research at present remains insufficient. Notably, there exists a complex and dynamic coupling among clearance subsystems: disorders of meningeal lymphatics and microvascular structural damage often form a vicious cycle with waste accumulation and inflammatory activation, thereby accelerating the neurodegeneration process (<xref ref-type="bibr" rid="ref12">Cai et al., 2024</xref>; <xref ref-type="bibr" rid="ref14">Chen et al., 2024</xref>; <xref ref-type="bibr" rid="ref53">Wen et al., 2024</xref>; <xref ref-type="bibr" rid="ref60">Zedde and Pascarella, 2024</xref>). Although advanced imaging techniques can dynamically scan perivascular space changes, there is still a lack of direct evidence linking these with the microstructural&#x2013;functional causal chain, which limits precise risk prediction and target identification (<xref ref-type="bibr" rid="ref46">Sacchi et al., 2024</xref>). Most existing studies are cross-sectional or single-factor investigations, lacking systematic, multimodal, dynamic, and longitudinal multi-factorial coupling models and integrated mechanism analysis. Future research should focus on synergistic analyses combining high-resolution multimodal imaging and molecular mechanisms, aiming to achieve multivariable, network-based, and precise interventions.</p>
</sec>
<sec id="sec26">
<label>4.3.4</label>
<title>Translational applications of artificial intelligence (AI) modeling, imaging analysis, and novel neuroregulation Technologies in glymphatic system functional interventions</title>
<p>AI modeling and advanced multimodal imaging techniques are gradually transforming both the basic research and clinical translation landscape of the glymphatic system. AI-based machine learning can deeply explore risk prediction of core factors such as AQP4 polymorphisms (<xref ref-type="bibr" rid="ref6">Beer et al., 2024</xref>). In addition, AI-based velocimetry algorithms enable high-precision, noninvasive quantification of intracerebral cerebrospinal fluid dynamics parameters, providing a novel technical approach for elucidating brain clearance mechanisms in high-dimensional spaces and for early evaluation and classification of brain diseases such as AD (<xref ref-type="bibr" rid="ref11">Boster et al., 2023</xref>). The new generation of multimodal MRI (such as diffusion tensor imaging and perivascular space visualization) shows significant value in early screening and dynamic monitoring of disease progression in brain disorders such as autism, helping to identify the association between glymphatic dysfunction and the evolution of disease phenotypes (<xref ref-type="bibr" rid="ref52">Wang et al., 2023</xref>; <xref ref-type="bibr" rid="ref49">Soares et al., 2024</xref>). It is worth emphasizing that imaging-guided, subject-specific modeling of the glymphatic system not only provides an accurate reflection of each individual&#x2019;s brain clearance function, but also reveals a close association between reduced glymphatic transport efficiency and increased amyloid deposition in the brain (<xref ref-type="bibr" rid="ref30">Johnson et al., 2023</xref>). This quantitative model offers a scientific basis for risk identification and precise intervention, and further promotes the in-depth understanding of the mechanisms underlying neurodegenerative diseases as well as individualized management. Moreover, neuroregulation techniques and Adeno-Associated Virus Serotype 1 (AAV1)-based delivery provide feasible pathways for targeted repair of the glymphatic network and gene therapy, with promising progress observed in both rat/human models and special environments (such as space) (<xref ref-type="bibr" rid="ref55">Wu et al., 2019</xref>; <xref ref-type="bibr" rid="ref35">Mathiesen et al., 2023</xref>; <xref ref-type="bibr" rid="ref49">Soares et al., 2024</xref>). However, challenges such as dynamic imaging resolution, clinical standardization, multifactorial mechanism modeling, and AI interpretability remain, leaving a gap between technological advances and precise intervention (<xref ref-type="bibr" rid="ref62">Zhang et al., 2023</xref>; <xref ref-type="bibr" rid="ref66">Zhu et al., 2023</xref>). In the future, it will be essential to strengthen the deep integration of multicenter, large-sample, dynamic longitudinal data with AI modeling, and to promote full-chain coordination and innovation across imaging, AI, neuroregulation, and molecular mechanism domains. Addressing challenges related to standardization and interpretability is crucial to support the precise and personalized management of glymphatic function and related NDs.</p>
<p>In summary, the glymphatic system and its molecular networks, especially AQP4 polarization, provide new theoretical and technological foundations for the etiology and intervention of NDs. Future research should focus on: (1) optimizing and standardizing <italic>in vivo</italic> imaging and molecular dynamic assessment for precise quantification of glymphatic function; (2) elucidating regulatory networks and cross-species mechanisms of key molecules such as AQP4 polarization; (3) integrating multidimensional regulatory factors and waste clearance to construct macro&#x2013;micro dynamic coupling models; and (4) advancing the application of AI and imaging technologies in multi-center and diverse environments to improve early screening, targeted prevention, and personalized management of NDs. We look forward to more researchers joining the field to drive breakthroughs in brain health and disease prevention.</p>
</sec>
</sec>
<sec id="sec27">
<label>4.4</label>
<title>Advantages and limitations</title>
<p>This study offers several distinct advantages. Firstly, this study is the first to conduct a scientometric analysis specifically focusing on the relationship between the glymphatic system and NDs. It provides a foundational basis and direction for systematic research in this field. Secondly, by integrating multiple scientometric methods, this study presents a comprehensive and multi-level refined analysis of research hotspots, temporal trends, and collaborative networks. This approach not only overcomes the limitations of traditional reviews, but also uncovers new potential connections between glymphatic mechanisms and NDs. Finally, we used data from Web of Science, Scopus, and PubMed Central, which significantly broadens the scope of the literature surveyed and improves the reliability and representativeness of the results.</p>
<p>Nevertheless, several limitations should be noted in this study. Firstly, this study only included literature published in English during the selection process, which may have resulted in the omission of important studies published in other languages. Secondly, citation counts are influenced by the time of publication, meaning that recently published studies in the current year that have not yet accumulated many citations may not have been fully represented. Despite these limitations, the literature analyzed in this study still provides a systematic overview of the latest research progress on the meningeal lymphatic system in the field of NDs, highlighting major research directions and future trends.</p>
</sec>
</sec>
<sec sec-type="conclusions" id="sec28">
<label>5</label>
<title>Conclusion</title>
<p>This analytical framework provides a powerful tool for the systematic study of the knowledge diffusion pathways and cutting-edge advancements in the glymphatic system within NDs. Over the past thirteen years, research on the glymphatic system in NDs has shown a rapid developmental trend globally. The significant increase in the number of annual publications fully demonstrates that the importance of research in this field is becoming increasingly prominent. In this field, the most influential scholar is Nedergaard Maiken, the most representative journals are the Frontiers series, and the University of Rochester in the United States is the most influential institution. Current research hotspots are mainly focused on the metabolic clearance mechanisms mediated by AQP4 polarization, as well as the regulatory roles of sleep, aging, and inflammation. The primary disease models involved include AD and PD. The frontier research directions point towards non-invasive imaging technologies such as multimodal MRI (<xref ref-type="bibr" rid="ref63">Zhou, 2016</xref>) and AI-driven intervention paradigms as well as multiomic confirmations (<xref ref-type="bibr" rid="ref64">Zhou, 2021</xref>). Looking ahead, research on the glymphatic system in NDs should focus on promoting multicenter, large-sample international collaborative studies. This study examines the developmental trends of research on this topic from the perspective of bibliometrics and provides a comprehensive summary of the research hotspots in this field. Moreover, these findings also offer valuable references for researchers to select appropriate publication channels and establish scientific research partnerships.</p>
</sec>
</body>
<back>
<sec sec-type="author-contributions" id="sec29">
<title>Author contributions</title>
<p>YW: Methodology, Writing &#x2013; original draft, Validation, Data curation, Visualization, Investigation, Software, Formal analysis, Conceptualization, Resources, Writing &#x2013; review &#x0026; editing. QL: Formal analysis, Conceptualization, Writing &#x2013; original draft. JW: Methodology, Investigation, Writing &#x2013; original draft. KM: Supervision, Formal analysis, Writing &#x2013; review &#x0026; editing. LZ: Writing &#x2013; review &#x0026; editing, Investigation, Methodology. FY: Validation, Supervision, Data curation, Writing &#x2013; review &#x0026; editing, Funding acquisition.</p>
</sec>
<sec sec-type="funding-information" id="sec30">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. The research team formally acknowledges financial sponsorship encompassing investigation design, scholarly composition, and knowledge dissemination through ethical funding declaration protocols. This work was supported by the Natural Science Foundation of Hubei Province (2022CFB570), the Science and Technology Research Project of the Hubei Provincial Department of Health (WJ2023M158), and the Scientific Research Project of Hubei Provincial Department of Education (B2022171).</p>
</sec>
<sec sec-type="COI-statement" id="sec31">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec32">
<title>Generative AI statement</title>
<p>The authors declare that no Gen AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec33">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abbott</surname> <given-names>N. J.</given-names></name> <name><surname>Pizzo</surname> <given-names>M. E.</given-names></name> <name><surname>Preston</surname> <given-names>J. E.</given-names></name> <name><surname>Janigro</surname> <given-names>D.</given-names></name> <name><surname>Thorne</surname> <given-names>R. G.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of brain barriers in fluid movement in the CNS: is there a &#x201C;glymphatic&#x201D; system?</article-title> <source>Acta Neuropathol.</source> <volume>135</volume>, <fpage>387</fpage>&#x2013;<lpage>407</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00401-018-1812-4</pub-id>, PMID: <pub-id pub-id-type="pmid">29428972</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Guerrero</surname> <given-names>J.</given-names></name> <name><surname>Santiago-Balmaseda</surname> <given-names>A.</given-names></name> <name><surname>Jeronimo-Aguilar</surname> <given-names>P.</given-names></name> <name><surname>Vargas-Rodr&#x00ED;guez</surname> <given-names>I.</given-names></name> <name><surname>Cadena-Su&#x00E1;rez</surname> <given-names>A. R.</given-names></name> <name><surname>S&#x00E1;nchez-Garibay</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Alzheimer&#x2019;s disease: an updated overview of its genetics</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume>:<fpage>3754</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms24043754</pub-id>, PMID: <pub-id pub-id-type="pmid">36835161</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andriuta</surname> <given-names>D.</given-names></name> <name><surname>Ottoy</surname> <given-names>J.</given-names></name> <name><surname>Ruthirakuhan</surname> <given-names>M.</given-names></name> <name><surname>Feliciano</surname> <given-names>G.</given-names></name> <name><surname>Dilliott</surname> <given-names>A. A.</given-names></name> <name><surname>Hegele</surname> <given-names>R. A.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseases</article-title>. <source>Alzheimers Dement.</source> <volume>20</volume>, <fpage>5800</fpage>&#x2013;<lpage>5808</lpage>. doi: <pub-id pub-id-type="doi">10.1002/alz.14081</pub-id>, PMID: <pub-id pub-id-type="pmid">38961774</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Avilez-Avilez</surname> <given-names>J. J.</given-names></name> <name><surname>Medina-Flores</surname> <given-names>M. F.</given-names></name> <name><surname>G&#x00F3;mez-Gonzalez</surname> <given-names>B.</given-names></name></person-group> (<year>2024</year>). <article-title>Sleep loss impairs blood-brain barrier function: cellular and molecular mechanisms</article-title>. <source>Vitam. Horm.</source> <volume>126</volume>, <fpage>77</fpage>&#x2013;<lpage>96</lpage>. doi: <pub-id pub-id-type="doi">10.1016/bs.vh.2024.02.003</pub-id>, PMID: <pub-id pub-id-type="pmid">39029977</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bah</surname> <given-names>T. M.</given-names></name> <name><surname>Siler</surname> <given-names>D. A.</given-names></name> <name><surname>Ibrahim</surname> <given-names>A. H.</given-names></name> <name><surname>Cetas</surname> <given-names>J. S.</given-names></name> <name><surname>Alkayed</surname> <given-names>N. J.</given-names></name></person-group> (<year>2023</year>). <article-title>Fluid dynamics in aging-related dementias</article-title>. <source>Neurobiol. Dis.</source> <volume>177</volume>:<fpage>105986</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2022.105986</pub-id>, PMID: <pub-id pub-id-type="pmid">36603747</pub-id></citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beer</surname> <given-names>S.</given-names></name> <name><surname>Elmenhorst</surname> <given-names>D.</given-names></name> <name><surname>Bischof</surname> <given-names>G. N.</given-names></name> <name><surname>Ramirez</surname> <given-names>A.</given-names></name> <name><surname>Bauer</surname> <given-names>A.</given-names></name> <name><surname>Drzezga</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Explainable artificial intelligence identifies an AQP4 polymorphism-based risk score associated with brain amyloid burden</article-title>. <source>Neurobiol. Aging</source> <volume>143</volume>, <fpage>19</fpage>&#x2013;<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2024.08.002</pub-id>, PMID: <pub-id pub-id-type="pmid">39208715</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benveniste</surname> <given-names>H.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Koundal</surname> <given-names>S.</given-names></name> <name><surname>Sanggaard</surname> <given-names>S.</given-names></name> <name><surname>Lee</surname> <given-names>H.</given-names></name> <name><surname>Wardlaw</surname> <given-names>J.</given-names></name></person-group> (<year>2019</year>). <article-title>The Glymphatic system and waste clearance with brain aging: a review</article-title>. <source>Gerontology</source> <volume>65</volume>, <fpage>106</fpage>&#x2013;<lpage>119</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000490349</pub-id>, PMID: <pub-id pub-id-type="pmid">29996134</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beschorner</surname> <given-names>N.</given-names></name> <name><surname>Nedergaard</surname> <given-names>M.</given-names></name></person-group> (<year>2024</year>). <article-title>Glymphatic system dysfunction in neurodegenerative diseases</article-title>. <source>Curr. Opin. Neurol.</source> <volume>37</volume>, <fpage>182</fpage>&#x2013;<lpage>188</lpage>. doi: <pub-id pub-id-type="doi">10.1097/WCO.0000000000001252</pub-id>, PMID: <pub-id pub-id-type="pmid">38345416</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname> <given-names>T.</given-names></name> <name><surname>Soares</surname> <given-names>G. A. B. E.</given-names></name> <name><surname>Chopra</surname> <given-names>H.</given-names></name> <name><surname>Rahman</surname> <given-names>M. M.</given-names></name> <name><surname>Hasan</surname> <given-names>Z.</given-names></name> <name><surname>Swain</surname> <given-names>S. S.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders</article-title>. <source>Materials (Basel)</source> <volume>15</volume>:<fpage>804</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ma15030804</pub-id>, PMID: <pub-id pub-id-type="pmid">35160749</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boland</surname> <given-names>B.</given-names></name> <name><surname>Yu</surname> <given-names>W. H.</given-names></name> <name><surname>Corti</surname> <given-names>O.</given-names></name> <name><surname>Mollereau</surname> <given-names>B.</given-names></name> <name><surname>Henriques</surname> <given-names>A.</given-names></name> <name><surname>Bezard</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing</article-title>. <source>Nat. Rev. Drug Discov.</source> <volume>17</volume>, <fpage>660</fpage>&#x2013;<lpage>688</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nrd.2018.109</pub-id>, PMID: <pub-id pub-id-type="pmid">30116051</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boster</surname> <given-names>K. A. S.</given-names></name> <name><surname>Cai</surname> <given-names>S.</given-names></name> <name><surname>Ladr&#x00F3;n-de-Guevara</surname> <given-names>A.</given-names></name> <name><surname>Sun</surname> <given-names>J.</given-names></name> <name><surname>Zheng</surname> <given-names>X.</given-names></name> <name><surname>Du</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Artificial intelligence velocimetry reveals in vivo flow rates, pressure gradients, and shear stresses in murine perivascular flows</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>120</volume>:<fpage>e2217744120</fpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.2217744120</pub-id>, PMID: <pub-id pub-id-type="pmid">36989300</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Leng</surname> <given-names>S.</given-names></name> <name><surname>Ma</surname> <given-names>Y.</given-names></name> <name><surname>Jiang</surname> <given-names>Q.</given-names></name> <name><surname>Wen</surname> <given-names>Q.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: a vicious cycle</article-title>. <source>Neurobiol. Dis.</source> <volume>192</volume>:<fpage>106426</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2024.106426</pub-id>, PMID: <pub-id pub-id-type="pmid">38331353</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>C.-P.</given-names></name> <name><surname>Wu</surname> <given-names>C.-W.</given-names></name> <name><surname>Chern</surname> <given-names>Y.</given-names></name></person-group> (<year>2024</year>). <article-title>Metabolic dysregulation in Huntington&#x2019;s disease: neuronal and glial perspectives</article-title>. <source>Neurobiol. Dis.</source> <volume>201</volume>:<fpage>106672</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.nbd.2024.106672</pub-id>, PMID: <pub-id pub-id-type="pmid">39306013</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Pan</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>Q.</given-names></name> <name><surname>Li</surname> <given-names>G.</given-names></name> <name><surname>Chen</surname> <given-names>G.</given-names></name> <name><surname>Li</surname> <given-names>W.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>The interplay between meningeal lymphatic vessels and Neuroinflammation in neurodegenerative diseases</article-title>. <source>Curr. Neuropharmacol.</source> <volume>22</volume>, <fpage>1016</fpage>&#x2013;<lpage>1032</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1570159X21666221115150253</pub-id>, PMID: <pub-id pub-id-type="pmid">36380442</pub-id></citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Da Mesquita</surname> <given-names>S.</given-names></name> <name><surname>Louveau</surname> <given-names>A.</given-names></name> <name><surname>Vaccari</surname> <given-names>A.</given-names></name> <name><surname>Smirnov</surname> <given-names>I.</given-names></name> <name><surname>Cornelison</surname> <given-names>R. C.</given-names></name> <name><surname>Kingsmore</surname> <given-names>K. M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Functional aspects of meningeal lymphatics in ageing and Alzheimer&#x2019;s disease</article-title>. <source>Nature</source> <volume>560</volume>, <fpage>185</fpage>&#x2013;<lpage>191</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41586-018-0368-8</pub-id>, PMID: <pub-id pub-id-type="pmid">30046111</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>X.-B.</given-names></name> <name><surname>Wang</surname> <given-names>X.-X.</given-names></name> <name><surname>Xia</surname> <given-names>D.-H.</given-names></name> <name><surname>Liu</surname> <given-names>H.</given-names></name> <name><surname>Tian</surname> <given-names>H.-Y.</given-names></name> <name><surname>Fu</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson&#x2019;s disease</article-title>. <source>Nat. Med.</source> <volume>27</volume>, <fpage>411</fpage>&#x2013;<lpage>418</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41591-020-01198-1</pub-id>, PMID: <pub-id pub-id-type="pmid">33462448</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>S.</given-names></name> <name><surname>Wu</surname> <given-names>C.</given-names></name> <name><surname>Zou</surname> <given-names>P.</given-names></name> <name><surname>Deng</surname> <given-names>Q.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Li</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>High-intensity interval training ameliorates Alzheimer&#x2019;s disease-like pathology by regulating astrocyte phenotype-associated AQP4 polarization</article-title>. <source>Theranostics</source> <volume>13</volume>, <fpage>3434</fpage>&#x2013;<lpage>3450</lpage>. doi: <pub-id pub-id-type="doi">10.7150/thno.81951</pub-id>, PMID: <pub-id pub-id-type="pmid">37351177</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomolka</surname> <given-names>R. S.</given-names></name> <name><surname>Hablitz</surname> <given-names>L. M.</given-names></name> <name><surname>Mestre</surname> <given-names>H.</given-names></name> <name><surname>Giannetto</surname> <given-names>M.</given-names></name> <name><surname>Du</surname> <given-names>T.</given-names></name> <name><surname>Hauglund</surname> <given-names>N. L.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Loss of aquaporin-4 results in glymphatic system dysfunction via brain-wide interstitial fluid stagnation</article-title>. <source>eLife</source> <volume>12</volume>:<fpage>e82232</fpage>. doi: <pub-id pub-id-type="doi">10.7554/eLife.82232</pub-id>, PMID: <pub-id pub-id-type="pmid">36757363</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gottesman</surname> <given-names>R. F.</given-names></name> <name><surname>Lutsey</surname> <given-names>P. L.</given-names></name> <name><surname>Benveniste</surname> <given-names>H.</given-names></name> <name><surname>Brown</surname> <given-names>D. L.</given-names></name> <name><surname>Full</surname> <given-names>K. M.</given-names></name> <name><surname>Lee</surname> <given-names>J.-M.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Impact of sleep disorders and disturbed sleep on brain health: a scientific statement from the American Heart Association</article-title>. <source>Stroke</source> <volume>55</volume>, <fpage>e61</fpage>&#x2013;<lpage>e76</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STR.0000000000000453</pub-id>, PMID: <pub-id pub-id-type="pmid">38235581</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>S.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Yin</surname> <given-names>Y.</given-names></name></person-group> (<year>2022</year>). <article-title>Microglia polarization from M1 to M2 in neurodegenerative diseases</article-title>. <source>Front. Aging Neurosci.</source> <volume>14</volume>:<fpage>815347</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnagi.2022.815347</pub-id>, PMID: <pub-id pub-id-type="pmid">35250543</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hablitz</surname> <given-names>L. M.</given-names></name> <name><surname>Pl&#x00E1;</surname> <given-names>V.</given-names></name> <name><surname>Giannetto</surname> <given-names>M.</given-names></name> <name><surname>Vinitsky</surname> <given-names>H. S.</given-names></name> <name><surname>St&#x00E6;ger</surname> <given-names>F. F.</given-names></name> <name><surname>Metcalfe</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Circadian control of brain glymphatic and lymphatic fluid flow</article-title>. <source>Nat. Commun.</source> <volume>11</volume>:<fpage>4411</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-020-18115-2</pub-id>, PMID: <pub-id pub-id-type="pmid">32879313</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hablitz</surname> <given-names>L. M.</given-names></name> <name><surname>Vinitsky</surname> <given-names>H. S.</given-names></name> <name><surname>Sun</surname> <given-names>Q.</given-names></name> <name><surname>St&#x00E6;ger</surname> <given-names>F. F.</given-names></name> <name><surname>Sigurdsson</surname> <given-names>B.</given-names></name> <name><surname>Mortensen</surname> <given-names>K. N.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Increased glymphatic influx is correlated with high EEG delta power and low heart rate in mice under anesthesia</article-title>. <source>Sci. Adv.</source> <volume>5</volume>:<fpage>eaav5447</fpage>. doi: <pub-id pub-id-type="doi">10.1126/sciadv.aav5447</pub-id>, PMID: <pub-id pub-id-type="pmid">30820460</pub-id></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname> <given-names>I. F.</given-names></name> <name><surname>Ismail</surname> <given-names>O.</given-names></name> <name><surname>Machhada</surname> <given-names>A.</given-names></name> <name><surname>Colgan</surname> <given-names>N.</given-names></name> <name><surname>Ohene</surname> <given-names>Y.</given-names></name> <name><surname>Nahavandi</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Impaired glymphatic function and clearance of tau in an Alzheimer&#x2019;s disease model</article-title>. <source>Brain</source> <volume>143</volume>, <fpage>2576</fpage>&#x2013;<lpage>2593</lpage>. doi: <pub-id pub-id-type="doi">10.1093/brain/awaa179</pub-id>, PMID: <pub-id pub-id-type="pmid">32705145</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname> <given-names>J. E.</given-names></name></person-group> (<year>2005</year>). <article-title>An index to quantify an individual&#x2019;s scientific research output</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>102</volume>, <fpage>16569</fpage>&#x2013;<lpage>16572</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0507655102</pub-id>, PMID: <pub-id pub-id-type="pmid">16275915</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname> <given-names>Z.</given-names></name> <name><surname>Jiang</surname> <given-names>P.</given-names></name> <name><surname>Su</surname> <given-names>S.</given-names></name> <name><surname>Zhou</surname> <given-names>H.</given-names></name></person-group> (<year>2022</year>). <article-title>Hotspots and trends in multiple myeloma bone diseases: a bibliometric visualization analysis</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>:<fpage>1003228</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2022.1003228</pub-id>, PMID: <pub-id pub-id-type="pmid">36313356</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname> <given-names>C.</given-names></name> <name><surname>Ren</surname> <given-names>W.</given-names></name> <name><surname>Wang</surname> <given-names>B.</given-names></name> <name><surname>Fu</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>Q.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>A bibliometric and knowledge-map analysis of the glymphatic system from 2012 to 2022</article-title>. <source>Front. Mol. Neurosci.</source> <volume>16</volume>:<fpage>1148179</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnmol.2023.1148179</pub-id>, PMID: <pub-id pub-id-type="pmid">37701852</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iliff</surname> <given-names>J. J.</given-names></name> <name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Liao</surname> <given-names>Y.</given-names></name> <name><surname>Plogg</surname> <given-names>B. A.</given-names></name> <name><surname>Peng</surname> <given-names>W.</given-names></name> <name><surname>Gundersen</surname> <given-names>G. A.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid &#x03B2;</article-title>. <source>Sci. Transl. Med.</source> <volume>4</volume>:<fpage>147ra111</fpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.3003748</pub-id>, PMID: <pub-id pub-id-type="pmid">22896675</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname> <given-names>K.</given-names></name> <name><surname>Yamada</surname> <given-names>K.</given-names></name> <name><surname>Nishiyama</surname> <given-names>R.</given-names></name> <name><surname>Hashimoto</surname> <given-names>T.</given-names></name> <name><surname>Nishida</surname> <given-names>I.</given-names></name> <name><surname>Abe</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration</article-title>. <source>J. Exp. Med.</source> <volume>219</volume>:<fpage>e20211275</fpage>. doi: <pub-id pub-id-type="doi">10.1084/jem.20211275</pub-id>, PMID: <pub-id pub-id-type="pmid">35212707</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jessen</surname> <given-names>N. A.</given-names></name> <name><surname>Munk</surname> <given-names>A. S. F.</given-names></name> <name><surname>Lundgaard</surname> <given-names>I.</given-names></name> <name><surname>Nedergaard</surname> <given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>The Glymphatic system: a beginner&#x2019;s guide</article-title>. <source>Neurochem. Res.</source> <volume>40</volume>, <fpage>2583</fpage>&#x2013;<lpage>2599</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11064-015-1581-6</pub-id>, PMID: <pub-id pub-id-type="pmid">25947369</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname> <given-names>M. J.</given-names></name> <name><surname>Abdelmalik</surname> <given-names>M. R. A.</given-names></name> <name><surname>Baidoo</surname> <given-names>F. A.</given-names></name> <name><surname>Badachhape</surname> <given-names>A.</given-names></name> <name><surname>Hughes</surname> <given-names>T. J. R.</given-names></name> <name><surname>Hossain</surname> <given-names>S. S.</given-names></name></person-group> (<year>2023</year>). <article-title>Image-guided subject-specific modeling of glymphatic transport and amyloid deposition</article-title>. <source>Comput. Methods Appl. Mech. Eng.</source> <volume>417</volume>:<fpage>116449</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cma.2023.116449</pub-id>, PMID: <pub-id pub-id-type="pmid">38249440</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kritsilis</surname> <given-names>M.</given-names></name> <name><surname>Rizou</surname> <given-names>V.</given-names></name> <name><surname>Koutsoudaki</surname> <given-names>P. N.</given-names></name> <name><surname>Evangelou</surname> <given-names>K.</given-names></name> <name><surname>Gorgoulis</surname> <given-names>V. G.</given-names></name> <name><surname>Papadopoulos</surname> <given-names>D.</given-names></name></person-group> (<year>2018</year>). <article-title>Ageing, cellular senescence and neurodegenerative disease</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume>:<fpage>2937</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms19102937</pub-id>, PMID: <pub-id pub-id-type="pmid">30261683</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>S.</given-names></name> <name><surname>Chen</surname> <given-names>L.</given-names></name> <name><surname>Lin</surname> <given-names>L.</given-names></name> <name><surname>Xu</surname> <given-names>C.</given-names></name> <name><surname>Qiu</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2024b</year>). <article-title>Global trends in tumor microenvironment-related research on tumor vaccine: a review and bibliometric analysis</article-title>. <source>Front. Immunol.</source> <volume>15</volume>:<fpage>1341596</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2024.1341596</pub-id>, PMID: <pub-id pub-id-type="pmid">38380323</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>N.</given-names></name> <name><surname>Yu</surname> <given-names>W.</given-names></name> <name><surname>Sun</surname> <given-names>M.</given-names></name> <name><surname>Zhou</surname> <given-names>D.</given-names></name> <name><surname>Sun</surname> <given-names>J.</given-names></name> <name><surname>Jiang</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2024a</year>). <article-title>Research trends and hotspots of ferroptosis in neurodegenerative diseases from 2013 to 2023: a bibliometrics study</article-title>. <source>Heliyon</source> <volume>10</volume>:<fpage>e29418</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.heliyon.2024.e29418</pub-id>, PMID: <pub-id pub-id-type="pmid">38638970</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malis</surname> <given-names>V.</given-names></name> <name><surname>Bae</surname> <given-names>W. C.</given-names></name> <name><surname>Yamamoto</surname> <given-names>A.</given-names></name> <name><surname>McEvoy</surname> <given-names>L. K.</given-names></name> <name><surname>McDonald</surname> <given-names>M. A.</given-names></name> <name><surname>Miyazaki</surname> <given-names>M.</given-names></name></person-group> (<year>2024</year>). <article-title>Age-related decline of intrinsic cerebrospinal fluid outflow in healthy humans detected with non-contrast spin-labeling MR imaging</article-title>. <source>Magn. Reson. Med. Sci.</source> <volume>23</volume>, <fpage>66</fpage>&#x2013;<lpage>79</lpage>. doi: <pub-id pub-id-type="doi">10.2463/mrms.mp.2022-0117</pub-id>, PMID: <pub-id pub-id-type="pmid">36529500</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mathiesen</surname> <given-names>B. K.</given-names></name> <name><surname>Miyakoshi</surname> <given-names>L. M.</given-names></name> <name><surname>Cederroth</surname> <given-names>C. R.</given-names></name> <name><surname>Tserga</surname> <given-names>E.</given-names></name> <name><surname>Versteegh</surname> <given-names>C.</given-names></name> <name><surname>Bork</surname> <given-names>P. A. R.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Delivery of gene therapy through a cerebrospinal fluid conduit to rescue hearing in adult mice</article-title>. <source>Sci. Transl. Med.</source> <volume>15</volume>:<fpage>eabq3916</fpage>. doi: <pub-id pub-id-type="doi">10.1126/scitranslmed.abq3916</pub-id>, PMID: <pub-id pub-id-type="pmid">37379370</pub-id></citation></ref>
<ref id="ref36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mestre</surname> <given-names>H.</given-names></name> <name><surname>Hablitz</surname> <given-names>L. M.</given-names></name> <name><surname>Xavier</surname> <given-names>A. L.</given-names></name> <name><surname>Feng</surname> <given-names>W.</given-names></name> <name><surname>Zou</surname> <given-names>W.</given-names></name> <name><surname>Pu</surname> <given-names>T.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Aquaporin-4-dependent glymphatic solute transport in the rodent brain</article-title>. <source>eLife</source> <volume>7</volume>:<fpage>e40070</fpage>. doi: <pub-id pub-id-type="doi">10.7554/eLife.40070</pub-id>, PMID: <pub-id pub-id-type="pmid">30561329</pub-id></citation></ref>
<ref id="ref37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mestre</surname> <given-names>H.</given-names></name> <name><surname>Kostrikov</surname> <given-names>S.</given-names></name> <name><surname>Mehta</surname> <given-names>R. I.</given-names></name> <name><surname>Nedergaard</surname> <given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>Perivascular spaces, glymphatic dysfunction, and small vessel disease</article-title>. <source>Clin. Sci. (Lond.)</source> <volume>131</volume>, <fpage>2257</fpage>&#x2013;<lpage>2274</lpage>. doi: <pub-id pub-id-type="doi">10.1042/CS20160381</pub-id>, PMID: <pub-id pub-id-type="pmid">28798076</pub-id></citation></ref>
<ref id="ref38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mestre</surname> <given-names>H.</given-names></name> <name><surname>Mori</surname> <given-names>Y.</given-names></name> <name><surname>Nedergaard</surname> <given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>The brain&#x2019;s Glymphatic system: current controversies</article-title>. <source>Trends Neurosci.</source> <volume>43</volume>, <fpage>458</fpage>&#x2013;<lpage>466</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tins.2020.04.003</pub-id>, PMID: <pub-id pub-id-type="pmid">32423764</pub-id></citation></ref>
<ref id="ref39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naganawa</surname> <given-names>S.</given-names></name> <name><surname>Taoka</surname> <given-names>T.</given-names></name> <name><surname>Ito</surname> <given-names>R.</given-names></name> <name><surname>Kawamura</surname> <given-names>M.</given-names></name></person-group> (<year>2024</year>). <article-title>The Glymphatic system in humans: investigations with magnetic resonance imaging</article-title>. <source>Investig. Radiol.</source> <volume>59</volume>, <fpage>1</fpage>&#x2013;<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1097/RLI.0000000000000969</pub-id>, PMID: <pub-id pub-id-type="pmid">36897826</pub-id></citation></ref>
<ref id="ref40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nedergaard</surname> <given-names>M.</given-names></name> <name><surname>Goldman</surname> <given-names>S. A.</given-names></name></person-group> (<year>2020</year>). <article-title>Glymphatic failure as a final common pathway to dementia</article-title>. <source>Science</source> <volume>370</volume>, <fpage>50</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.abb8739</pub-id>, PMID: <pub-id pub-id-type="pmid">33004510</pub-id></citation></ref>
<ref id="ref41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ozdinler</surname> <given-names>P. H.</given-names></name></person-group> (<year>2024</year>). <article-title>Sleep apnea and amyotrophic lateral sclerosis: cause, correlation, any relation?</article-title> <source>Brain Sci.</source> <volume>14</volume>:<fpage>978</fpage>. doi: <pub-id pub-id-type="doi">10.3390/brainsci14100978</pub-id>, PMID: <pub-id pub-id-type="pmid">39451992</pub-id></citation></ref>
<ref id="ref42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Premi</surname> <given-names>E.</given-names></name> <name><surname>Diano</surname> <given-names>M.</given-names></name> <name><surname>Mattioli</surname> <given-names>I.</given-names></name> <name><surname>Altomare</surname> <given-names>D.</given-names></name> <name><surname>Cantoni</surname> <given-names>V.</given-names></name> <name><surname>Bocchetta</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study</article-title>. <source>Brain Commun</source> <volume>6</volume>:<fpage>fcae185</fpage>. doi: <pub-id pub-id-type="doi">10.1093/braincomms/fcae185</pub-id>, PMID: <pub-id pub-id-type="pmid">39015769</pub-id></citation></ref>
<ref id="ref43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname> <given-names>M. K.</given-names></name> <name><surname>Mestre</surname> <given-names>H.</given-names></name> <name><surname>Nedergaard</surname> <given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>The glymphatic pathway in neurological disorders</article-title>. <source>Lancet Neurol.</source> <volume>17</volume>, <fpage>1016</fpage>&#x2013;<lpage>1024</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1474-4422(18)30318-1</pub-id>, PMID: <pub-id pub-id-type="pmid">30353860</pub-id></citation></ref>
<ref id="ref44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname> <given-names>M. U.</given-names></name> <name><surname>Sehar</surname> <given-names>N.</given-names></name> <name><surname>Rasool</surname> <given-names>I.</given-names></name> <name><surname>Aldossari</surname> <given-names>R. M.</given-names></name> <name><surname>Wani</surname> <given-names>A. B.</given-names></name> <name><surname>Rashid</surname> <given-names>S. M.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Glymphatic pathway: an emerging perspective in the pathophysiology of neurodegenerative diseases</article-title>. <source>Int. J. Geriatr. Psychiatry</source> <volume>39</volume>:<fpage>e6104</fpage>. doi: <pub-id pub-id-type="doi">10.1002/gps.6104</pub-id>, PMID: <pub-id pub-id-type="pmid">38877354</pub-id></citation></ref>
<ref id="ref45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ringstad</surname> <given-names>G.</given-names></name> <name><surname>Valnes</surname> <given-names>L. M.</given-names></name> <name><surname>Dale</surname> <given-names>A. M.</given-names></name> <name><surname>Pripp</surname> <given-names>A. H.</given-names></name> <name><surname>Vatnehol</surname> <given-names>S.-A. S.</given-names></name> <name><surname>Emblem</surname> <given-names>K. E.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Brain-wide glymphatic enhancement and clearance in humans assessed with MRI</article-title>. <source>JCI Insight</source> <volume>3</volume>:<fpage>e121537</fpage>. doi: <pub-id pub-id-type="doi">10.1172/jci.insight.121537</pub-id>, PMID: <pub-id pub-id-type="pmid">29997300</pub-id></citation></ref>
<ref id="ref46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacchi</surname> <given-names>L.</given-names></name> <name><surname>D&#x2019;Agata</surname> <given-names>F.</given-names></name> <name><surname>Campisi</surname> <given-names>C.</given-names></name> <name><surname>Arcaro</surname> <given-names>M.</given-names></name> <name><surname>Carandini</surname> <given-names>T.</given-names></name> <name><surname>&#x00D6;rzsik</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>A &#x201C;glympse&#x201D; into neurodegeneration: diffusion MRI and cerebrospinal fluid aquaporin-4 for the assessment of glymphatic system in Alzheimer&#x2019;s disease and other dementias</article-title>. <source>Hum. Brain Mapp.</source> <volume>45</volume>:<fpage>e26805</fpage>. doi: <pub-id pub-id-type="doi">10.1002/hbm.26805</pub-id></citation></ref>
<ref id="ref47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Si</surname> <given-names>X.</given-names></name> <name><surname>Dai</surname> <given-names>S.</given-names></name> <name><surname>Fang</surname> <given-names>Y.</given-names></name> <name><surname>Tang</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>Z.</given-names></name> <name><surname>Li</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Matrix metalloproteinase-9 inhibition prevents aquaporin-4 depolarization-mediated glymphatic dysfunction in Parkinson&#x2019;s disease</article-title>. <source>J. Adv. Res.</source> <volume>56</volume>, <fpage>125</fpage>&#x2013;<lpage>136</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jare.2023.03.004</pub-id>, PMID: <pub-id pub-id-type="pmid">36940850</pub-id></citation></ref>
<ref id="ref48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname> <given-names>M.</given-names></name> <name><surname>Wang</surname> <given-names>M. X.</given-names></name> <name><surname>Ismail</surname> <given-names>O.</given-names></name> <name><surname>Braun</surname> <given-names>M.</given-names></name> <name><surname>Schindler</surname> <given-names>A. G.</given-names></name> <name><surname>Reemmer</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>2022</year>). <article-title>Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid &#x03B2; plaque formation in mice</article-title>. <source>Alzheimer's Res Ther</source> <volume>14</volume>:<fpage>59</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13195-022-00999-5</pub-id>, PMID: <pub-id pub-id-type="pmid">35473943</pub-id></citation></ref>
<ref id="ref49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname> <given-names>B.</given-names></name> <name><surname>Ong</surname> <given-names>J.</given-names></name> <name><surname>Waisberg</surname> <given-names>E.</given-names></name> <name><surname>Sarker</surname> <given-names>P.</given-names></name> <name><surname>Zaman</surname> <given-names>N.</given-names></name> <name><surname>Tavakkoli</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Imaging in spaceflight associated neuro-ocular syndrome (SANS): current technology and future directions in modalities</article-title>. <source>Life Sci Space Res (Amst)</source> <volume>42</volume>, <fpage>40</fpage>&#x2013;<lpage>46</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lssr.2024.04.004</pub-id>, PMID: <pub-id pub-id-type="pmid">39067989</pub-id></citation></ref>
<ref id="ref50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>N.</given-names></name> <name><surname>Xing</surname> <given-names>Y.</given-names></name> <name><surname>Jiang</surname> <given-names>J.</given-names></name> <name><surname>Wu</surname> <given-names>P.</given-names></name> <name><surname>Qing</surname> <given-names>L.</given-names></name> <name><surname>Tang</surname> <given-names>J.</given-names></name></person-group> (<year>2023</year>). <article-title>Knowledge mapping and emerging trends of ferroptosis in ischemia reperfusion injury research: a bibliometric analysis (2013-2022)</article-title>. <source>Heliyon</source> <volume>9</volume>:<fpage>e20363</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.heliyon.2023.e20363</pub-id>, PMID: <pub-id pub-id-type="pmid">37767486</pub-id></citation></ref>
<ref id="ref51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thipani Madhu</surname> <given-names>M.</given-names></name> <name><surname>Balaji</surname> <given-names>O.</given-names></name> <name><surname>Kandi</surname> <given-names>V.</given-names></name> <name><surname>Ca</surname> <given-names>J.</given-names></name> <name><surname>Harikrishna</surname> <given-names>G. V.</given-names></name> <name><surname>Metta</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Role of the Glymphatic system in Alzheimer&#x2019;s disease and treatment approaches: a narrative review</article-title>. <source>Cureus</source> <volume>16</volume>:<fpage>e63448</fpage>. doi: <pub-id pub-id-type="doi">10.7759/cureus.63448</pub-id>, PMID: <pub-id pub-id-type="pmid">39077280</pub-id></citation></ref>
<ref id="ref52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>M.</given-names></name> <name><surname>Xu</surname> <given-names>D.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <name><surname>Jiang</surname> <given-names>H.</given-names></name></person-group> (<year>2023</year>). <article-title>Application of multimodal MRI in the early diagnosis of autism Spectrum disorders: a review</article-title>. <source>Diagnostics (Basel)</source> <volume>13</volume>:<fpage>3027</fpage>. doi: <pub-id pub-id-type="doi">10.3390/diagnostics13193027</pub-id>, PMID: <pub-id pub-id-type="pmid">37835770</pub-id></citation></ref>
<ref id="ref53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname> <given-names>Q.</given-names></name> <name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Haacke</surname> <given-names>E. M.</given-names></name> <name><surname>Jiang</surname> <given-names>Q.</given-names></name> <name><surname>Hu</surname> <given-names>J.</given-names></name></person-group> (<year>2024</year>). <article-title>Contribution of direct cerebral vascular transport in brain substance clearance</article-title>. <source>Aging Dis.</source> <volume>15</volume>, <fpage>584</fpage>&#x2013;<lpage>600</lpage>. doi: <pub-id pub-id-type="doi">10.14336/AD.2023.0426</pub-id>, PMID: <pub-id pub-id-type="pmid">37611901</pub-id></citation></ref>
<ref id="ref54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>H.</given-names></name> <name><surname>Politis</surname> <given-names>M.</given-names></name> <name><surname>Rabiner</surname> <given-names>E. A.</given-names></name> <name><surname>Middleton</surname> <given-names>L. T.</given-names></name></person-group> (<year>2020</year>). <article-title>Novel PET biomarkers to disentangle molecular pathways across age-related neurodegenerative diseases</article-title>. <source>Cells</source> <volume>9</volume>:<fpage>2581</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cells9122581</pub-id>, PMID: <pub-id pub-id-type="pmid">33276490</pub-id></citation></ref>
<ref id="ref55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>G.</given-names></name> <name><surname>Jiang</surname> <given-names>Q.</given-names></name> <name><surname>Cui</surname> <given-names>T.</given-names></name> <name><surname>Liu</surname> <given-names>X.</given-names></name> <name><surname>Gong</surname> <given-names>D.</given-names></name> <name><surname>Yin</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>The glymphatic system delivery enhances the transduction efficiency of AAV1 to brain endothelial cells in adult mice</article-title>. <source>J. Neurosci. Methods</source> <volume>328</volume>:<fpage>108441</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jneumeth.2019.108441</pub-id>, PMID: <pub-id pub-id-type="pmid">31574288</pub-id></citation></ref>
<ref id="ref56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>L.</given-names></name> <name><surname>Kang</surname> <given-names>H.</given-names></name> <name><surname>Xu</surname> <given-names>Q.</given-names></name> <name><surname>Chen</surname> <given-names>M. J.</given-names></name> <name><surname>Liao</surname> <given-names>Y.</given-names></name> <name><surname>Thiyagarajan</surname> <given-names>M.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Sleep drives metabolite clearance from the adult brain</article-title>. <source>Science</source> <volume>342</volume>, <fpage>373</fpage>&#x2013;<lpage>377</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1241224</pub-id>, PMID: <pub-id pub-id-type="pmid">24136970</pub-id></citation></ref>
<ref id="ref57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname> <given-names>Y.</given-names></name> <name><surname>Yu</surname> <given-names>Q.</given-names></name> <name><surname>Zhi</surname> <given-names>H.</given-names></name> <name><surname>Peng</surname> <given-names>H.</given-names></name> <name><surname>Xie</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Advances in the study of the glymphatic system and aging</article-title>. <source>CNS Neurosci. Ther.</source> <volume>30</volume>:<fpage>e14803</fpage>. doi: <pub-id pub-id-type="doi">10.1111/cns.14803</pub-id>, PMID: <pub-id pub-id-type="pmid">38887168</pub-id></citation></ref>
<ref id="ref58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname> <given-names>K.</given-names></name> <name><surname>Iwatsubo</surname> <given-names>T.</given-names></name></person-group> (<year>2024</year>). <article-title>Involvement of the glymphatic/meningeal lymphatic system in Alzheimer&#x2019;s disease: insights into proteostasis and future directions</article-title>. <source>Cell. Mol. Life Sci.</source> <volume>81</volume>:<fpage>192</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s00018-024-05225-z</pub-id>, PMID: <pub-id pub-id-type="pmid">38652179</pub-id></citation></ref>
<ref id="ref59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yankova</surname> <given-names>G.</given-names></name> <name><surname>Bogomyakova</surname> <given-names>O.</given-names></name> <name><surname>Tulupov</surname> <given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>The glymphatic system and meningeal lymphatics of the brain: new understanding of brain clearance</article-title>. <source>Rev. Neurosci.</source> <volume>32</volume>, <fpage>693</fpage>&#x2013;<lpage>705</lpage>. doi: <pub-id pub-id-type="doi">10.1515/revneuro-2020-0106</pub-id>, PMID: <pub-id pub-id-type="pmid">33618444</pub-id></citation></ref>
<ref id="ref60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zedde</surname> <given-names>M.</given-names></name> <name><surname>Pascarella</surname> <given-names>R.</given-names></name></person-group> (<year>2024</year>). <article-title>The cerebrovascular side of plasticity: microvascular architecture across health and neurodegenerative and vascular diseases</article-title>. <source>Brain Sci.</source> <volume>14</volume>:<fpage>983</fpage>. doi: <pub-id pub-id-type="doi">10.3390/brainsci14100983</pub-id>, PMID: <pub-id pub-id-type="pmid">39451997</pub-id></citation></ref>
<ref id="ref61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeppenfeld</surname> <given-names>D. M.</given-names></name> <name><surname>Simon</surname> <given-names>M.</given-names></name> <name><surname>Haswell</surname> <given-names>J. D.</given-names></name> <name><surname>D&#x2019;Abreo</surname> <given-names>D.</given-names></name> <name><surname>Murchison</surname> <given-names>C.</given-names></name> <name><surname>Quinn</surname> <given-names>J. F.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Association of Perivascular Localization of Aquaporin-4 with cognition and Alzheimer disease in aging brains</article-title>. <source>JAMA Neurol.</source> <volume>74</volume>, <fpage>91</fpage>&#x2013;<lpage>99</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamaneurol.2016.4370</pub-id>, PMID: <pub-id pub-id-type="pmid">27893874</pub-id></citation></ref>
<ref id="ref62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Y.</given-names></name> <name><surname>Zhang</surname> <given-names>C.</given-names></name> <name><surname>He</surname> <given-names>X.-Z.</given-names></name> <name><surname>Li</surname> <given-names>Z.-H.</given-names></name> <name><surname>Meng</surname> <given-names>J.-C.</given-names></name> <name><surname>Mao</surname> <given-names>R.-T.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Interaction between the Glymphatic system and &#x03B1;-Synuclein in Parkinson&#x2019;s disease</article-title>. <source>Mol. Neurobiol.</source> <volume>60</volume>, <fpage>2209</fpage>&#x2013;<lpage>2222</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12035-023-03212-2</pub-id>, PMID: <pub-id pub-id-type="pmid">36637746</pub-id></citation></ref>
<ref id="ref63"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y.</given-names></name></person-group> (<year>2016</year>). <source>Functional neuroimaging with multiple modalities: Principles, device and applications</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Nova Science Publishers</publisher-name>.</citation></ref>
<ref id="ref64"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>Y.</given-names></name></person-group> (<year>2021</year>). <source>Imaging and multiomic biomarker applications: Advances in early Alzheimer&#x2019;s disease</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Nova Science Publishers</publisher-name>.</citation></ref>
<ref id="ref65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>C.</given-names></name> <name><surname>Jiang</surname> <given-names>X.</given-names></name> <name><surname>Guan</surname> <given-names>X.</given-names></name> <name><surname>Guo</surname> <given-names>T.</given-names></name> <name><surname>Wu</surname> <given-names>J.</given-names></name> <name><surname>Wu</surname> <given-names>H.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease</article-title>. <source>Eur. J. Neurol.</source> <volume>31</volume>:<fpage>e16521</fpage>. doi: <pub-id pub-id-type="doi">10.1111/ene.16521</pub-id>, PMID: <pub-id pub-id-type="pmid">39425566</pub-id></citation></ref>
<ref id="ref66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>B.</given-names></name> <name><surname>Zhou</surname> <given-names>W.</given-names></name> <name><surname>Chen</surname> <given-names>C.</given-names></name> <name><surname>Cao</surname> <given-names>A.</given-names></name> <name><surname>Luo</surname> <given-names>W.</given-names></name> <name><surname>Huang</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>AQP4 is an emerging regulator of pathological pain: a narrative review</article-title>. <source>Cell. Mol. Neurobiol.</source> <volume>43</volume>, <fpage>3997</fpage>&#x2013;<lpage>4005</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10571-023-01422-9</pub-id>, PMID: <pub-id pub-id-type="pmid">37864629</pub-id></citation></ref>
<ref id="ref67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>W.</given-names></name> <name><surname>Pu</surname> <given-names>T.</given-names></name> <name><surname>Feng</surname> <given-names>W.</given-names></name> <name><surname>Lu</surname> <given-names>M.</given-names></name> <name><surname>Zheng</surname> <given-names>Y.</given-names></name> <name><surname>Du</surname> <given-names>R.</given-names></name> <etal/></person-group>. (<year>2019</year>). <article-title>Blocking meningeal lymphatic drainage aggravates Parkinson&#x2019;s disease-like pathology in mice overexpressing mutated &#x03B1;-synuclein</article-title>. <source>Transl Neurodegener</source> <volume>8</volume>:<fpage>7</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40035-019-0147-y</pub-id>, PMID: <pub-id pub-id-type="pmid">30867902</pub-id></citation></ref>
</ref-list>
</back>
</article>